<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7731333</article-id><article-id pub-id-type="pmid">33271809</article-id><article-id pub-id-type="doi">10.3390/molecules25235666</article-id><article-id pub-id-type="publisher-id">molecules-25-05666</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Biophysical Characterization and Anticancer Activities of Photosensitive Phytoanthraquinones Represented by Hypericin and Its Model Compounds</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Verebov&#x000e1;</surname><given-names>Val&#x000e9;ria</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05666">1</xref></contrib><contrib contrib-type="author"><name><surname>Bene&#x00161;</surname><given-names>Ji&#x00159;&#x000ed;</given-names></name><xref ref-type="aff" rid="af2-molecules-25-05666">2</xref></contrib><contrib contrib-type="author"><name><surname>Stani&#x0010d;ov&#x000e1;</surname><given-names>Jana</given-names></name><xref ref-type="aff" rid="af1-molecules-25-05666">1</xref><xref ref-type="aff" rid="af2-molecules-25-05666">2</xref><xref rid="c1-molecules-25-05666" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Lupi&#x000e1;&#x000f1;ez</surname><given-names>Jos&#x000e9; Antonio</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>P&#x000e9;rez-Jim&#x000e9;nez</surname><given-names>Amalia</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Rufino-Palomares</surname><given-names>Eva E.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-05666"><label>1</label>Department of Chemistry, Biochemistry and Biophysics, University of Veterinary Medicine &#x00026; Pharmacy, Komensk&#x000e9;ho 73, 041 81 Ko&#x00161;ice, Slovakia; <email>valeria.verebova@uvlf.sk</email></aff><aff id="af2-molecules-25-05666"><label>2</label>Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University, Kate&#x00159;insk&#x000e1; 1, 121 08 Prague, Czech Republic; <email>jiri.benes@lf1.cuni.cz</email></aff><author-notes><corresp id="c1-molecules-25-05666"><label>*</label>Correspondence: <email>jana.stanicova@uvlf.sk</email>; Tel.: +421-915-984-613</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2020</year></pub-date><volume>25</volume><issue>23</issue><elocation-id>5666</elocation-id><history><date date-type="received"><day>27</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>28</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Photosensitive compounds found in herbs have been reported in recent years as having a variety of interesting medicinal and biological activities. In this review, we focus on photosensitizers such as hypericin and its model compounds emodin, quinizarin, and danthron, which have antiviral, antifungal, antineoplastic, and antitumor effects. They can be utilized as potential agents in photodynamic therapy, especially in photodynamic therapy (PDT) for cancer. We aimed to give a comprehensive summary of the physical and chemical properties of these interesting molecules, emphasizing their mechanism of action in relation to their different interactions with biomacromolecules, specifically with DNA. </p></abstract><kwd-group><kwd>natural photosensitive compounds</kwd><kwd>anticancer activity</kwd><kwd>hypericin</kwd><kwd>emodin</kwd><kwd>quinizarin</kwd><kwd>danthron</kwd><kwd>interaction</kwd><kwd>DNA</kwd></kwd-group></article-meta></front><body><sec id="sec1-molecules-25-05666"><title>1. Photodynamic Therapy</title><p>Photodynamic therapy (PDT) is part of photochemotherapy and requires the presence of a photosensitive substance (drug, PS), oxygen, and a powerful light source in the area of absorption of the PS used. The main requirements for activating the properties of a PS are its selective accumulation in tumor tissue, high intensity of absorption in the visible and near-infrared region of the spectrum, low level of dark toxicity, and absence of side-effects [<xref rid="B1-molecules-25-05666" ref-type="bibr">1</xref>,<xref rid="B2-molecules-25-05666" ref-type="bibr">2</xref>]. Selective accumulation and retention of PS in tumor tissues rather than in the surrounding healthy tissue lead to selective destruction of the tumor in PDT, while the surrounding healthy tissue remains intact. Such selectivity is one of the biggest advantages of this method, which may be substituted in some cases for chemotherapy, radiotherapy, or surgery in the treatment of cancer. Due to drug excretion [<xref rid="B3-molecules-25-05666" ref-type="bibr">3</xref>] and redistribution, the effective therapeutic dose entering tumor cells is only a fraction of the administered PS. Administration of increased amounts of therapeutics is not possible because they have cytotoxic effects, which could cause significant toxicity in healthy cells. It is very important therefore to find alternative approaches, which increase the efficacy of the drug dose in the tumor and decrease the dose in healthy tissue [<xref rid="B4-molecules-25-05666" ref-type="bibr">4</xref>]. Higher selectivity of PSs for tumor cells can be achieved by combining them with transport agents, which preferentially interact with tumor cells, ensure the selective accumulation of the drug within the diseased tissue, and deliver the desired therapeutic drug concentration to a targeted site in the patient&#x02019;s body. Transport systems commonly used for photosensitizers are polymers, liposomes, oil emulsions, certain metals, some proteins, and carbon-based nanoparticles [<xref rid="B5-molecules-25-05666" ref-type="bibr">5</xref>,<xref rid="B6-molecules-25-05666" ref-type="bibr">6</xref>,<xref rid="B7-molecules-25-05666" ref-type="bibr">7</xref>,<xref rid="B8-molecules-25-05666" ref-type="bibr">8</xref>,<xref rid="B9-molecules-25-05666" ref-type="bibr">9</xref>,<xref rid="B10-molecules-25-05666" ref-type="bibr">10</xref>]. Stable and biocompatible transport systems with a long half-life in the blood are ideal. Selective drug delivery to tumor tissue, transport of nanoparticles containing a PS, and a tumor cell with a receptor is the objectives for achieving high selectivity and low drug concentration [<xref rid="B11-molecules-25-05666" ref-type="bibr">11</xref>]. Several research groups have confirmed the hypothesis that one possible approach to achieving these goals is to prepare low-density lipoprotein (LDL)-based particles [<xref rid="B12-molecules-25-05666" ref-type="bibr">12</xref>,<xref rid="B13-molecules-25-05666" ref-type="bibr">13</xref>,<xref rid="B14-molecules-25-05666" ref-type="bibr">14</xref>,<xref rid="B15-molecules-25-05666" ref-type="bibr">15</xref>,<xref rid="B16-molecules-25-05666" ref-type="bibr">16</xref>,<xref rid="B17-molecules-25-05666" ref-type="bibr">17</xref>].</p><sec id="sec1dot1-molecules-25-05666"><title>1.1. PDT in Cancer Therapy</title><p>PDT has been a promising, non-invasive method for the treatment of certain types of cancer for more than 25 years [<xref rid="B18-molecules-25-05666" ref-type="bibr">18</xref>,<xref rid="B19-molecules-25-05666" ref-type="bibr">19</xref>,<xref rid="B20-molecules-25-05666" ref-type="bibr">20</xref>,<xref rid="B21-molecules-25-05666" ref-type="bibr">21</xref>,<xref rid="B22-molecules-25-05666" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-05666" ref-type="bibr">23</xref>]; in addition, PDT has also been studied in various non-oncological applications; leishmaniasis [<xref rid="B24-molecules-25-05666" ref-type="bibr">24</xref>], psoriasis [<xref rid="B25-molecules-25-05666" ref-type="bibr">25</xref>,<xref rid="B26-molecules-25-05666" ref-type="bibr">26</xref>], age-related macular degeneration [<xref rid="B27-molecules-25-05666" ref-type="bibr">27</xref>,<xref rid="B28-molecules-25-05666" ref-type="bibr">28</xref>], hyperplasia [<xref rid="B27-molecules-25-05666" ref-type="bibr">27</xref>], restenosis [<xref rid="B25-molecules-25-05666" ref-type="bibr">25</xref>], and in cardiology [<xref rid="B29-molecules-25-05666" ref-type="bibr">29</xref>], urology [<xref rid="B30-molecules-25-05666" ref-type="bibr">30</xref>], immunology [<xref rid="B31-molecules-25-05666" ref-type="bibr">31</xref>], ophthalmology [<xref rid="B28-molecules-25-05666" ref-type="bibr">28</xref>,<xref rid="B32-molecules-25-05666" ref-type="bibr">32</xref>], dental medicine [<xref rid="B33-molecules-25-05666" ref-type="bibr">33</xref>,<xref rid="B34-molecules-25-05666" ref-type="bibr">34</xref>], and dermatology [<xref rid="B35-molecules-25-05666" ref-type="bibr">35</xref>,<xref rid="B36-molecules-25-05666" ref-type="bibr">36</xref>]. The combination of light and PS also shows promising results in the treatment of bacterial, fungal, parasitic, and viral infections [<xref rid="B37-molecules-25-05666" ref-type="bibr">37</xref>,<xref rid="B38-molecules-25-05666" ref-type="bibr">38</xref>,<xref rid="B39-molecules-25-05666" ref-type="bibr">39</xref>,<xref rid="B40-molecules-25-05666" ref-type="bibr">40</xref>].</p><p>The basic process in tumor PDT is shown in the diagram in <xref ref-type="fig" rid="molecules-25-05666-f001">Figure 1</xref>. The photosensitizer is usually administered intravenously (systematically) or topically, and the administration of PS has also been studied orally, mostly in patients with extensive damage (not always caused by cancer) [<xref rid="B1-molecules-25-05666" ref-type="bibr">1</xref>,<xref rid="B41-molecules-25-05666" ref-type="bibr">41</xref>].</p><p>PS accumulates in the tumor tissue, which is subsequently irradiated with a light source of suitable wavelength, leading, in the presence of oxygen, to the formation of reactive oxygen species (ROS) and destruction of tissue and whole cells [<xref rid="B1-molecules-25-05666" ref-type="bibr">1</xref>,<xref rid="B41-molecules-25-05666" ref-type="bibr">41</xref>], while deactivation of important enzymes occurs and changes in the properties of biomacromolecules [<xref rid="B44-molecules-25-05666" ref-type="bibr">44</xref>]. After activation of the photoactive substance by light and its interaction with molecular oxygen, singlet oxygen is formed. The singlet oxygen released in this photochemical reaction is highly toxic and can directly cause the death of tumor cells, through apoptosis, necrosis, or autophagy mechanism [<xref rid="B45-molecules-25-05666" ref-type="bibr">45</xref>]. The release of singlet oxygen evokes oxidative stress, increases cytotoxicity, and DNA damage in cancer cells, modifies cellular metabolism, alters cancer cell death signaling pathways [<xref rid="B46-molecules-25-05666" ref-type="bibr">46</xref>]. It also damages the blood vessels in tumor cells, resulting in indirect cell death through hypoxia (deficiency of oxygen) or aging (cell starvation). Diffuse distance of singlet oxygen obtained from photobleaching experiments has been appointed as 10&#x02013;20 nm [<xref rid="B47-molecules-25-05666" ref-type="bibr">47</xref>]. More recent time-resolved phosphorescence measurements show higher diffuse distance corresponding to 100 nm [<xref rid="B48-molecules-25-05666" ref-type="bibr">48</xref>]. An explanation of this discrepancy was given by Hatz et al. [<xref rid="B48-molecules-25-05666" ref-type="bibr">48</xref>] considering a fact that singlet oxygen behaves as a selective rather than reactive intermediate upon encountering other molecules in the cell.</p><p>Tissue damage depends on the depth of light penetration used to activate the PS. Membranes are damaged by cell death, triggering a number of inflammatory and immune processes, which cascade and cause the death of other tumor cells [<xref rid="B49-molecules-25-05666" ref-type="bibr">49</xref>]. However, it was found out that singlet oxygen might cause membrane destruction directly. The cell membrane can be the main target of the singlet oxygen reaction for the bacterial membrane [<xref rid="B50-molecules-25-05666" ref-type="bibr">50</xref>] and eukaryotic plasma membrane [<xref rid="B51-molecules-25-05666" ref-type="bibr">51</xref>].</p><p>After surface irradiation PDT, the deeper connective tissues are only slightly damaged, so the patient&#x02019;s body can begin to restore the structure and flexibility of the damaged cells, and subsequently the tissues [<xref rid="B52-molecules-25-05666" ref-type="bibr">52</xref>,<xref rid="B53-molecules-25-05666" ref-type="bibr">53</xref>].</p></sec><sec id="sec1dot2-molecules-25-05666"><title>1.2. Physicochemical Mechanism of PDT</title><p>The photodynamic effect can be induced by two mechanisms called Type I and Type II (<xref ref-type="fig" rid="molecules-25-05666-f001">Figure 1</xref>&#x02014;Step 4). After photon absorption, the PS molecule goes from the ground state (S<sub>0</sub>) to the singlet excited state (S<sub>1</sub>). From this excited state, the PS can be returned to the ground state by energy emission through non-radiative and/or radiant processes (fluorescence). In its excited state, the PS can also spontaneously move from the singlet state S<sub>1</sub> to the excited triplet state (T<sub>1</sub>) by means of the intersystem conversion process. In this state, the transition to the ground state through a phosphorescence process can occur [<xref rid="B54-molecules-25-05666" ref-type="bibr">54</xref>].</p><p>The type I mechanism involves electron transfer reactions between the PS molecule in the excited states of S<sub>1</sub> and T<sub>1</sub> and the substrate. This process results in the formation of ionic radicals, which tend to react immediately with oxygen to form a mixture of highly reactive oxygen radicals, such as superoxide radical (<bold>&#x000b7;</bold>O<sub>2</sub>), hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), and hydroxyl radical (<bold>&#x000b7;</bold>OH), which oxidize a wide range of biomacromolecules [<xref rid="B2-molecules-25-05666" ref-type="bibr">2</xref>,<xref rid="B55-molecules-25-05666" ref-type="bibr">55</xref>].</p><p>The type II mechanism is characterized by energy transfer reactions between PS in the excited triplet state T<sub>1</sub> and molecular oxygen, which is also in the triplet ground state (T<sub>0</sub>). These reactions cause the formation of singlet oxygen (<sup>1</sup>O<sub>2</sub>), which is able to rapidly oxidize cellular structures such as proteins, lipids, nucleic acids [<xref rid="B56-molecules-25-05666" ref-type="bibr">56</xref>,<xref rid="B57-molecules-25-05666" ref-type="bibr">57</xref>], and organelles leading to tumor cell death [<xref rid="B58-molecules-25-05666" ref-type="bibr">58</xref>,<xref rid="B59-molecules-25-05666" ref-type="bibr">59</xref>]. This also means that PDT may be a useful alternative treatment for cancer cells resistant to chemotherapy [<xref rid="B60-molecules-25-05666" ref-type="bibr">60</xref>,<xref rid="B61-molecules-25-05666" ref-type="bibr">61</xref>].</p><p>The reaction mechanism depends on the following conditions. First, the location of the PS is crucial because most of the ROS are highly reactive and cannot move far from the point of origin before disappearing. Second, the relative number of target biomolecules is important [<xref rid="B43-molecules-25-05666" ref-type="bibr">43</xref>]. Davies (2003) calculated the percentage of <sup>1</sup>O<sub>2</sub> responses in leukocytes: protein 68.5%, ascorbate 16.5%, RNA 6.9%, DNA 5.5%, beta-carotene 0.9%, NADH/NADPH 0.69%, tocopherols 0.5%, reduced glutathione 0.4%, lipids 0.2%, and cholesterol 0.1% [<xref rid="B62-molecules-25-05666" ref-type="bibr">62</xref>]. This means that the distribution of <sup>1</sup>O<sub>2</sub> may vary in different cell targets. </p><p>Both mechanisms can occur simultaneously. Their proportional representation is significantly influenced by the PS, the substrate, the oxygen concentration, and the binding of PS to the substrate. In addition, the type II mechanism appears to be more efficient as it has a higher rate constant than electron transfer reactions (type I mechanism). As a result, energy transfer to other compounds that can compete with oxygen is less important, so type II is more often dominant [<xref rid="B58-molecules-25-05666" ref-type="bibr">58</xref>,<xref rid="B63-molecules-25-05666" ref-type="bibr">63</xref>].</p></sec><sec id="sec1dot3-molecules-25-05666"><title>1.3. PDT Applications</title><p>PDT currently occupies an increasingly important place in clinical medicine. Its most promising application is the treatment of small and superficial tumors, e.g., some types of skin, neck, stomach [<xref rid="B64-molecules-25-05666" ref-type="bibr">64</xref>], lung [<xref rid="B65-molecules-25-05666" ref-type="bibr">65</xref>,<xref rid="B66-molecules-25-05666" ref-type="bibr">66</xref>,<xref rid="B67-molecules-25-05666" ref-type="bibr">67</xref>], bronchial [<xref rid="B68-molecules-25-05666" ref-type="bibr">68</xref>] or oral cancer [<xref rid="B69-molecules-25-05666" ref-type="bibr">69</xref>], esophagus [<xref rid="B70-molecules-25-05666" ref-type="bibr">70</xref>,<xref rid="B71-molecules-25-05666" ref-type="bibr">71</xref>], bladder [<xref rid="B71-molecules-25-05666" ref-type="bibr">71</xref>,<xref rid="B72-molecules-25-05666" ref-type="bibr">72</xref>], brain [<xref rid="B73-molecules-25-05666" ref-type="bibr">73</xref>], prostate and pleura [<xref rid="B74-molecules-25-05666" ref-type="bibr">74</xref>] tumors, breast [<xref rid="B75-molecules-25-05666" ref-type="bibr">75</xref>] but also skin disease [<xref rid="B76-molecules-25-05666" ref-type="bibr">76</xref>], atherosclerosis, and viral diseases therapy [<xref rid="B77-molecules-25-05666" ref-type="bibr">77</xref>], including AIDS [<xref rid="B78-molecules-25-05666" ref-type="bibr">78</xref>]. </p><p>The future of PDT lies in efforts to find or synthesize new photosensitizers with properties allowing their greater selectivity for tumor tissues, and to find new approaches for the specific localization of already-known PS in tumor cells. This should contribute to the wider and more effective application of PDT in clinical practice. Targeted PDT has several advantages they are important in participation in the treatment of oncological diseases. Some of them are listed below: high selectivity, negligible side effects, low level of complications during and after treatment, high quality of life for patients, diagnostics and therapy in one step, and lower financial costs [<xref rid="B79-molecules-25-05666" ref-type="bibr">79</xref>]. It can be a convenient complementary therapeutic method to classical surgery, chemotherapy, radiotherapy, and independent limited diagnosis.</p></sec></sec><sec id="sec2-molecules-25-05666"><title>2. Plant-Derived Photosensitive Substances</title><p>Photoactive compounds occurring in medicinal plants with potential utilization in PDT have been found to be less toxic than synthetic agents. The reduction of side effects using natural PSs in cancer treatment is another advantage of this therapeutic approach. However, their clinical applications have been limited by several imperfections such as accumulation in tissues, a lack of chemical purity, or low penetration [<xref rid="B80-molecules-25-05666" ref-type="bibr">80</xref>]. Muniyandi et al. [<xref rid="B81-molecules-25-05666" ref-type="bibr">81</xref>] have published a comprehensive review article about the role of photoactive phytocompounds in PDT. Phototoxic effects, potential applications in the PDT of cancer of the main natural PSs groups (furanocoumarins, thiophenes, alkaloids, curcumins, polyacetylenes, and anthraquinones) have been described [<xref rid="B81-molecules-25-05666" ref-type="bibr">81</xref>]. Our paper focuses on the four anthraquinones, of which hypericin is the most promising PS in the PDT of cancer. With regard to the hydrophobicity of studied anthraquinones, which is important for their penetration through membranes, the following types of PSs have been distinguished.</p><sec><title>Types of Photosensitive Substances by Hydrophobicity</title><p>PDT either uses chemotherapeutics commonly applied in chemotherapy, which must also be photosensitive, or new PSs are proposed. All photosensitizers (except uroporphyrin and photophrin), which have been proposed as drugs for use in PDT, interact more or less with serum proteins after intravenous administration. From the point of view of PDT, however, the interaction of the drugs with DNA is also quite important, as it is necessary to disrupt and stop the division of tumor cells, and this can be achieved only through their interaction with DNA [<xref rid="B62-molecules-25-05666" ref-type="bibr">62</xref>,<xref rid="B82-molecules-25-05666" ref-type="bibr">82</xref>]. In some cases, this interaction is not very significant (as these drugs have a greater affinity for proteins), so it is necessary to find a transporter that will help deliver the drug to the cell nucleus, thereby mediating the drug&#x02013;DNA interaction [<xref rid="B83-molecules-25-05666" ref-type="bibr">83</xref>,<xref rid="B84-molecules-25-05666" ref-type="bibr">84</xref>]. Success in the treatment of cancer requires sufficiently hydrophobic drugs to cross the lipid membrane. For this reason, the hydrophobicity of drugs plays an important role in their distribution, metabolism, and excretion from the patient&#x000b4;s body. Due to these facts, we distinguish four groups of drugs with the ability to localize and accumulate in the tumor. Moreover, there are no rigid boundaries between these groups of drugs, and there is some overlapping between them, in some cases a continuous transition. </p><list list-type="order"><list-item><p>Hydrophobic PSs&#x02014;compounds requiring the presence of transporters, such as liposomes or Cremophor EL, or Tween 80. They have the ability to localize in the inner lipid part of lipoproteins, mainly in LDL and high-density lipoproteins (HDLs), but also in very-low-density lipoproteins (VLDLs). This group includes phthalocyanines (ZnPC, C1A1PC), naphthalocyanines (isoBOSINC), tin-etiopurpurine (SnET2) [<xref rid="B84-molecules-25-05666" ref-type="bibr">84</xref>], and hypericin [<xref rid="B85-molecules-25-05666" ref-type="bibr">85</xref>].</p></list-item><list-item><p>Amphiphilic PSs&#x02014;asymmetric compounds, which can be incorporated into the outer phospholipid and apoprotein layer of lipoprotein particles, e.g., disulfonates (TPPS<sub>2a</sub>, C1A1PCS<sub>2a</sub>), lutetium teraphyrin (LuTex), and monoaspartyl chlorine (MACE), which forms a barrier between albumin and HDL [<xref rid="B84-molecules-25-05666" ref-type="bibr">84</xref>]. Emodin can be included in this group [<xref rid="B86-molecules-25-05666" ref-type="bibr">86</xref>].</p></list-item><list-item><p>Hydrophilic PSs&#x02014;drugs that predominantly bind to albumins and globulins, e.g., tetra-sulfone derivates of tetraphenylporfin (TPPS<sub>3</sub> and TPPS<sub>4</sub>) and chloroaluminum phthalocyanine (C1A1PCS<sub>3</sub> and C1A1PCS<sub>4</sub>) [<xref rid="B84-molecules-25-05666" ref-type="bibr">84</xref>].</p></list-item><list-item><p>Intercalators&#x02014;drugs that are used mainly in chemotherapy, which intercalate into DNA and are also photoactive, e.g., doxorubicin [<xref rid="B87-molecules-25-05666" ref-type="bibr">87</xref>], daunorubicin [<xref rid="B88-molecules-25-05666" ref-type="bibr">88</xref>], adriamycin [<xref rid="B89-molecules-25-05666" ref-type="bibr">89</xref>], quinizarin [<xref rid="B90-molecules-25-05666" ref-type="bibr">90</xref>], and danthron [<xref rid="B91-molecules-25-05666" ref-type="bibr">91</xref>].</p></list-item></list><p>In this work, we focused in more detail on a very prospective PS in PDT of cancer hypericin. During a study of hypericin molecule incorporation into biomacromolecules (we focused on DNA) model compounds are using for simplification of the problem. Anthraquinones emodin, quinizarin, and danthron represent a significantly smaller part of the larger hypericin molecule with the same chemical groups. This fact facilitates the creation of a proper model for interaction between hypericin and biomacromolecules. Moreover, chosen hypericin derivatives themselves originate from medicinal plants, as the PS can be utilized in PDT and their anticancer effects are known. With respect to the above-mentioned sorting of PSs into groups, they can be representatives of highly hydrophobic (hypericin), mildly hydrophobic (emodin), and intercalating molecules (quinizarin and danthron). </p><p>Scientists and physicians are currently working on how to increase the effectiveness of cancer treatment. One option that has been shown to be very effective is a combination of therapies (PDT and chemotherapy), which involve the direct or mediated interaction of anticancer drugs with DNA and other bioactive macromolecules (serum albumins, lipoproteins) [<xref rid="B92-molecules-25-05666" ref-type="bibr">92</xref>,<xref rid="B93-molecules-25-05666" ref-type="bibr">93</xref>,<xref rid="B94-molecules-25-05666" ref-type="bibr">94</xref>]. Hypericin, emodin, quinizarin, and danthron are examples of anticancer drugs which are chemotherapeutics synthesized by medicinal plants and PSs, and which can be used, in PDT. The discovery of new natural drugs is very important because they have many benefits for the patients. Drugs derived from medicinal plants are less toxic to the body, their use poses less risk of adverse side effects, does not depends on them, they are suitable for all age groups of patients, and can be easily combined with conventional drugs, i.e., do not show contraindications.</p></sec></sec><sec id="sec3-molecules-25-05666"><title>3. Hypericin</title><p>Hypericin, a naturally occurring pigment, is found in certain plant species of the genus <italic>Hypericum</italic>. The most important representative is Saint John&#x000b4;s Wort (<italic>Hypericum perforatum</italic>) from the family <italic>Hypericaceae</italic>, a plant with golden-yellow flowers that grows to a height of 30&#x02013;90 cm [<xref rid="B95-molecules-25-05666" ref-type="bibr">95</xref>]. Hypericin has also been reported as occurring in some species of Australian insects [<xref rid="B96-molecules-25-05666" ref-type="bibr">96</xref>]. Hypericin, 7,14 dione-1,3,4,6,8,12-hexahydroxy 10,11 dimethyl-phenanthrol [1,10,9,8-opgra] perylene (<xref ref-type="fig" rid="molecules-25-05666-f002">Figure 2</xref>) is an aromatic polycyclic dione, which exhibits a wide range of biological activities.</p><p>It has long been used to treat depression caused by a disorder of the brain neurotransmitters responsible for human moods [<xref rid="B98-molecules-25-05666" ref-type="bibr">98</xref>,<xref rid="B99-molecules-25-05666" ref-type="bibr">99</xref>]. Hypericin has antiviral [<xref rid="B100-molecules-25-05666" ref-type="bibr">100</xref>,<xref rid="B101-molecules-25-05666" ref-type="bibr">101</xref>] and antitumor activity [<xref rid="B102-molecules-25-05666" ref-type="bibr">102</xref>,<xref rid="B103-molecules-25-05666" ref-type="bibr">103</xref>,<xref rid="B104-molecules-25-05666" ref-type="bibr">104</xref>,<xref rid="B105-molecules-25-05666" ref-type="bibr">105</xref>] and is used to heal wounds, neuralgic sites, and hypertrophic scar [<xref rid="B106-molecules-25-05666" ref-type="bibr">106</xref>,<xref rid="B107-molecules-25-05666" ref-type="bibr">107</xref>,<xref rid="B108-molecules-25-05666" ref-type="bibr">108</xref>]. Hypericin has been demonstrated to be very effective on bacteria [<xref rid="B109-molecules-25-05666" ref-type="bibr">109</xref>,<xref rid="B110-molecules-25-05666" ref-type="bibr">110</xref>,<xref rid="B111-molecules-25-05666" ref-type="bibr">111</xref>,<xref rid="B112-molecules-25-05666" ref-type="bibr">112</xref>,<xref rid="B113-molecules-25-05666" ref-type="bibr">113</xref>,<xref rid="B114-molecules-25-05666" ref-type="bibr">114</xref>]. Studies of hypericin&#x000b4;s antiviral activity confirm that it is known to effectively deactivate enveloped viruses, but it is ineffective against non-enveloped viruses. The antiviral activity of hypericin has been demonstrated against several types of viruses: herpes simplex virus, murine cytomegalovirus, sindbis virus [<xref rid="B115-molecules-25-05666" ref-type="bibr">115</xref>,<xref rid="B116-molecules-25-05666" ref-type="bibr">116</xref>], hepatitis B [<xref rid="B117-molecules-25-05666" ref-type="bibr">117</xref>], anemia, some types of leukemic viruses [<xref rid="B118-molecules-25-05666" ref-type="bibr">118</xref>], and HIV [<xref rid="B119-molecules-25-05666" ref-type="bibr">119</xref>,<xref rid="B120-molecules-25-05666" ref-type="bibr">120</xref>,<xref rid="B121-molecules-25-05666" ref-type="bibr">121</xref>], so it has also been used in the clinical treatment of AIDS patients [<xref rid="B122-molecules-25-05666" ref-type="bibr">122</xref>]. Hypericin activity depends to a large extent on the presence of light and oxygen. These two factors determine the extent of its antiviral activity and both antiviral and antitumor activities increase significantly after visible light irradiation [<xref rid="B123-molecules-25-05666" ref-type="bibr">123</xref>].</p><p>Hypericin, together with two other hydroxyquinones, hypocrellin A and calphostin, is characterized by negligible dark toxicity, significant photocytotoxicity to tumor cells, intense absorption at higher wavelengths (&#x0003e;550 nm), higher selectivity for tumor tissues, and faster leaching than hematoporphyrins [<xref rid="B124-molecules-25-05666" ref-type="bibr">124</xref>]. Hypericin is soluble in most solvents. In organic solvents (DMSO, ethanol) its solution is red; in basic media, it is green; and in aqueous solutions, it forms purple dispersed particles [<xref rid="B125-molecules-25-05666" ref-type="bibr">125</xref>]. The absorption spectrum of hypericin in neutral organic solvents has two main transitions in the visible region, <italic>S</italic><sub>0</sub>&#x02192;<italic>S</italic><sub>1</sub> (500&#x02013;600 nm) and <italic>S</italic><sub>0</sub>&#x02192;<italic>S</italic><sub>2</sub> (425&#x02013;485 nm), and two intense absorption bands. Hypericin forms non-fluorescent aggregates in aqueous solutions. The absorption and fluorescence spectra of hypericin in hexane, chloroform, and toluene are similar to those in water, so it can be assumed that hypericin molecules also form aggregates in these solvents. An indicator of the formation of aggregates in solution is the absence of fluorescence [<xref rid="B126-molecules-25-05666" ref-type="bibr">126</xref>]. Several physical and chemical properties of hypericin are shown in <xref rid="molecules-25-05666-t001" ref-type="table">Table 1</xref>.</p><p>The photophysics of hypericin is very complicated, and some effort to interpret its photophysical and photochemical properties is necessary to elucidate its pharmacological and biological activities. Phenols are known to be good electron donors, while quinones act as electron acceptors. Hypericin contains both phenolic and quinone moieties. This structural characteristic places it in the group of amphi-electron compounds. The results of experiments suggest that hypericin has the potential to be a good oxidizing and reducing agent [<xref rid="B128-molecules-25-05666" ref-type="bibr">128</xref>]. At present, the mechanisms leading to the selective accumulation of hypericin in tumor tissue compared to normal tissue are not known, nor the mechanism of its antiviral and antitumor action has been clearly determined. Thomas et al. proposed a mechanism of hypericin activity that depends on the presence of molecular oxygen, consisting of transferring energy from the excited triplet state of hypericin to the ground state of molecular oxygen, thereby generating oxygen in the singlet state, which is a highly-reactive molecule [<xref rid="B129-molecules-25-05666" ref-type="bibr">129</xref>]. Singlet oxygen production has been theoretically confirmed [<xref rid="B118-molecules-25-05666" ref-type="bibr">118</xref>] and experimentally demonstrated in organic solvents and lipid media [<xref rid="B130-molecules-25-05666" ref-type="bibr">130</xref>,<xref rid="B131-molecules-25-05666" ref-type="bibr">131</xref>,<xref rid="B132-molecules-25-05666" ref-type="bibr">132</xref>]. Other studies suggest that although oxygen may play an important role in some cases, it is not always necessary for the antiviral activity of hypericin [<xref rid="B133-molecules-25-05666" ref-type="bibr">133</xref>]. According to the work of the J.W. Petrich group, the origin of the photoinduced antiviral activity of hypericin may lie in its ability to produce a local pH drop in cells after irradiation [<xref rid="B134-molecules-25-05666" ref-type="bibr">134</xref>]. The close relationship between the mechanism of hypericin antitumor activity and photoactivated local acidification in cells has been confirmed in experiments on tumor cell membrane experiments [<xref rid="B102-molecules-25-05666" ref-type="bibr">102</xref>].</p><p>Hypericin is currently considered as a potential antitumor drug in PDT. It belongs in the group of highly hydrophobic PSs (AlogP = 5.04) [<xref rid="B135-molecules-25-05666" ref-type="bibr">135</xref>]. Its cytotoxic and antitumor activity has been demonstrated, and its inhibitory effects on epidermal growth factor-R and a wide range of protein kinases (protein tyrosine kinase, MAP-kinase, and protein kinase C) [<xref rid="B136-molecules-25-05666" ref-type="bibr">136</xref>]. The significant photosensitivity properties of hypericin together with its selective uptake in tumor tissues, especially in bladder cancer cells and its minimal cytotoxicity in the dark, are major positive indications for the clinical use of hypericin in the photodynamic cancer treatment [<xref rid="B137-molecules-25-05666" ref-type="bibr">137</xref>]. Hypericin is a photosensitizer found in the endoplasmic reticulum, which, when activated by light, mediates the rapid emptying of calcium Ca<sup>2+</sup> from the endoplasmic reticulum, which is linked to programmed cell death [<xref rid="B138-molecules-25-05666" ref-type="bibr">138</xref>]. Although hypericin has been shown to be a potent inducer of cell death in PDT, some in vivo studies suggest that cells treated with PDT may activate rescue-signaling pathways, which may ultimately lead to tumor survival and recurrence [<xref rid="B18-molecules-25-05666" ref-type="bibr">18</xref>,<xref rid="B139-molecules-25-05666" ref-type="bibr">139</xref>].</p><p>Hypericin is a very good fluorescent probe for super-resolution microscopy [<xref rid="B140-molecules-25-05666" ref-type="bibr">140</xref>]. Knowledge of the distribution of this molecule in the individual components of a living system is essential in detecting the modes of action of hypericin in biological organisms. The accumulation of hypericin in cells is determined by the diffuse and soluble properties of the molecule. It is known that after the initial accumulation in the cell membranes (20 min), an increased concentration of hypericin in the cell nucleus is observed with increasing time [<xref rid="B141-molecules-25-05666" ref-type="bibr">141</xref>]. This indicates the possible interaction of hypericin with nucleic acids, the most essential component of the cell nucleus. Ultraviolet resonance Raman spectroscopy with 257 nm excitation was used to study nucleic acid-hypericin complexes. The excitation used amplifies the vibrational modes of nucleic acid bases. Resonance Raman spectra for complexes of polynucleotides with hypericin showed that hypericin preferentially interacts with purines at the N7 position, and this interaction is stronger in guanine than in adenine [<xref rid="B142-molecules-25-05666" ref-type="bibr">142</xref>]. In addition, the spectra of the complex of hypericin with polyrG and calf thymus DNA, which were studied by means of surface-enhanced Raman spectroscopy, are dominated by bands corresponding to hypericin vibrations. Based on the spectra obtained, the importance of the guanine base in the interaction of hypericin with nucleic acid was confirmed. The spectrum of the polyrG complex contains changes similar to those in the spectrum of the DNA complex. Based on these results, it can be assumed that DNA induces changes in the stretching vibrations of the hypericin skeleton associated with the vibrations of the hydroxyl groups, suggesting that the hydroxyl groups of hypericin participate in the interaction with nucleic acid [<xref rid="B143-molecules-25-05666" ref-type="bibr">143</xref>].</p><p>The mechanism of hypericin distribution in tissues, cells, and cellular organelles is also thought to be a relatively complex process, which is affected by hypericin concentration, incubation time, and properties of biological units. The bio distribution of hypericin in human organisms also depends on the mode of transport in the bloodstream. Hypericin binds to serum proteins, where lipoprotein particles appear to be a more efficient transporter than albumin. The interaction of hypericin with albumin is specific [<xref rid="B144-molecules-25-05666" ref-type="bibr">144</xref>], while its interaction with lipoproteins is non-specific [<xref rid="B145-molecules-25-05666" ref-type="bibr">145</xref>]. After binding with macromolecules (lipid structures, serum proteins, and sugars), hypericin forms biologically active monomers with an emission band around 600 nm, thus overcoming problems with its solubility in physiological solutions, which is very important in terms of its activity [<xref rid="B97-molecules-25-05666" ref-type="bibr">97</xref>,<xref rid="B137-molecules-25-05666" ref-type="bibr">137</xref>].</p></sec><sec id="sec4-molecules-25-05666"><title>4. Emodin</title><p>Emodin, (1,3,8-trihydroxy-6-methylanthraquinone, <xref ref-type="fig" rid="molecules-25-05666-f003">Figure 3</xref>) is an anthraquinone derivate, a naturally-occurring pigment isolated from the underground part of the traditional Chinese medicinal plant <italic>Rheum palmatum</italic>, which is used mainly for its antitumor, immunosuppressive, antiinflammatory [<xref rid="B146-molecules-25-05666" ref-type="bibr">146</xref>], antibacterial, diuretic, laxative [<xref rid="B147-molecules-25-05666" ref-type="bibr">147</xref>], antiulcerogenic (antiulcer) [<xref rid="B148-molecules-25-05666" ref-type="bibr">148</xref>], and vasorelaxant effects [<xref rid="B149-molecules-25-05666" ref-type="bibr">149</xref>]. It is also found in other plant species, such as <italic>Cassia</italic>, <italic>Aloe</italic>, and <italic>Rhamnus</italic> [<xref rid="B150-molecules-25-05666" ref-type="bibr">150</xref>,<xref rid="B151-molecules-25-05666" ref-type="bibr">151</xref>,<xref rid="B152-molecules-25-05666" ref-type="bibr">152</xref>,<xref rid="B153-molecules-25-05666" ref-type="bibr">153</xref>,<xref rid="B154-molecules-25-05666" ref-type="bibr">154</xref>]. In practice, it is available in the form of an orange crystalline substance. It is insoluble in aqueous media, and it forms aggregates (mostly in the acidic pH range). Emodin shows poor solubility in chloroform, ether, and benzene, but is highly soluble in DMSO and ethanol.</p><p>The antiviral properties of emodin have also been confirmed, mainly on enveloped viruses. This property of emodin is related to its high affinity for the phospholipid membrane, in which it inhibits hydrophobic interactions between individual hydrocarbon chains [<xref rid="B155-molecules-25-05666" ref-type="bibr">155</xref>]. Emodin has been proposed as a major precursor of the microbial metabolic pathway in the isolation of hypericin [<xref rid="B156-molecules-25-05666" ref-type="bibr">156</xref>,<xref rid="B157-molecules-25-05666" ref-type="bibr">157</xref>]. It is a redox catalyst and plays an important role in many processes, such as electron transport, photosynthesis, or cellular respiration [<xref rid="B158-molecules-25-05666" ref-type="bibr">158</xref>]. Its effect on cell death has been widely studied both in the dark and after light activation [<xref rid="B155-molecules-25-05666" ref-type="bibr">155</xref>,<xref rid="B159-molecules-25-05666" ref-type="bibr">159</xref>]. The stimulatory effects and the prokinetic effect of emodin on gastrointestinal smooth muscle have been described in several studies [<xref rid="B147-molecules-25-05666" ref-type="bibr">147</xref>,<xref rid="B160-molecules-25-05666" ref-type="bibr">160</xref>]. In recent years, its effect on the contractility of smooth muscle cells has been studied [<xref rid="B161-molecules-25-05666" ref-type="bibr">161</xref>,<xref rid="B162-molecules-25-05666" ref-type="bibr">162</xref>].</p><p>In addition to the pharmacological properties mentioned above, emodin also has toxicological effects. Under aerobic conditions, it is photolabile in visible light and phototoxic in vitro and it can cause testicular toxicity in mice leading to hypospermatogenesis [<xref rid="B163-molecules-25-05666" ref-type="bibr">163</xref>,<xref rid="B164-molecules-25-05666" ref-type="bibr">164</xref>]. It inhibits protein kinase casein kinase II (CK2). Genetic disorder of the catalytic subunits of CK2 protein kinase leads to changes in sperm shape in mice during spermatogenesis and is also responsible for male infertility [<xref rid="B165-molecules-25-05666" ref-type="bibr">165</xref>,<xref rid="B166-molecules-25-05666" ref-type="bibr">166</xref>]. Several authors have studied the interaction of emodin with DNA [<xref rid="B167-molecules-25-05666" ref-type="bibr">167</xref>,<xref rid="B168-molecules-25-05666" ref-type="bibr">168</xref>,<xref rid="B169-molecules-25-05666" ref-type="bibr">169</xref>]; for example, it causes the formation of DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and inhibiting ATP hydrolysis by topoisomerase II [<xref rid="B170-molecules-25-05666" ref-type="bibr">170</xref>]. Emodin has a high binding affinity for serum proteins and is known to bind non-covalently to DNA in intact cells in the presence of serum proteins [<xref rid="B159-molecules-25-05666" ref-type="bibr">159</xref>]. The interaction of emodin with proteins has been studied using several techniques surface-enhanced Raman spectroscopy, NMR, fluorescence spectroscopy, circular dichroism, and the stopped-flow method [<xref rid="B171-molecules-25-05666" ref-type="bibr">171</xref>,<xref rid="B172-molecules-25-05666" ref-type="bibr">172</xref>,<xref rid="B173-molecules-25-05666" ref-type="bibr">173</xref>,<xref rid="B174-molecules-25-05666" ref-type="bibr">174</xref>]. The formation of emodin&#x02013;protein complexes is very important with regard to understanding the mode of drug delivery and transport in tumor cells [<xref rid="B174-molecules-25-05666" ref-type="bibr">174</xref>]. Emodin belongs in the drug of amphiphilic PSs with mild hydrophobic properties (Alog P = 2.568) [<xref rid="B135-molecules-25-05666" ref-type="bibr">135</xref>]. It has an anticancer effect on some types of human liver and lung tumors. However, the molecular mechanisms of emodin-mediated tumor regression have not been precisely defined [<xref rid="B150-molecules-25-05666" ref-type="bibr">150</xref>]. Emodin has specific antineuroectodermal tumor activity in vitro and in vivo [<xref rid="B175-molecules-25-05666" ref-type="bibr">175</xref>]. It suppresses tyrosine kinase activity on HER-2 breast cancer cells, inhibits the transformation of the phenotype of these cells, and can affect androgen receptors directly by inhibiting cell growth in prostate cancer cells [<xref rid="B146-molecules-25-05666" ref-type="bibr">146</xref>]. The antitumor activity of emodin on the human chronic myeloid leukemia cell line K562 has also been demonstrated in vitro and in vivo [<xref rid="B176-molecules-25-05666" ref-type="bibr">176</xref>]. Emodin is toxic for glioma cells by inhibiting their proliferation and inducing apoptosis of C6 cells [<xref rid="B177-molecules-25-05666" ref-type="bibr">177</xref>]. It is known to increase the sensitivity of tumor cells to chemotherapeutics, but the mechanism of the emodin-mediated chemotherapeutic effect on cancer cells has been the subject of intense study for many years [<xref rid="B150-molecules-25-05666" ref-type="bibr">150</xref>,<xref rid="B178-molecules-25-05666" ref-type="bibr">178</xref>]. Important physical properties of emodin are listed in <xref rid="molecules-25-05666-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec5-molecules-25-05666"><title>5. Quinizarin</title><p>Quinizarin (1,4-dihydroxyanthraquinone, <xref ref-type="fig" rid="molecules-25-05666-f004">Figure 4</xref>) is a polycyclic aromatic hydrocarbon containing two opposite carboxyl groups (C=O) at positions 9,10. It takes the form of a yellow crystalline substance and occurs in nature in plants (<italic>Aloe</italic>, Cascara Sagrada, Senna, and rhubarb), fungi, some lichens, and insects [<xref rid="B179-molecules-25-05666" ref-type="bibr">179</xref>]. Quinizarin is soluble in basic solutions, acetone, chloroform, and DMSO. It is almost insoluble in aqueous solutions, but its solubility increases with increasing temperature. It is used as a pesticide as a fungicide and as an additive in lubricants [<xref rid="B180-molecules-25-05666" ref-type="bibr">180</xref>]. In addition, it is used as a colorant in the food, textile, dyeing, and photographic industries [<xref rid="B181-molecules-25-05666" ref-type="bibr">181</xref>]. Quinizarin inhibits HIV proteinase [<xref rid="B182-molecules-25-05666" ref-type="bibr">182</xref>] and acts as a mutagenic agent on some mammalian bacteria [<xref rid="B183-molecules-25-05666" ref-type="bibr">183</xref>]. Immunological analysis studies have shown that it stimulates the P450 enzyme in rat epithelial and liver cells [<xref rid="B184-molecules-25-05666" ref-type="bibr">184</xref>].</p><p>The structure of quinizarin has been studied using several spectroscopic methods, such as fluorescence measurements [<xref rid="B185-molecules-25-05666" ref-type="bibr">185</xref>], resonance Raman and infrared spectroscopy [<xref rid="B186-molecules-25-05666" ref-type="bibr">186</xref>], and X-ray structural analysis [<xref rid="B187-molecules-25-05666" ref-type="bibr">187</xref>]. It has planar C<sub>2v</sub> molecular symmetry and crystallizes in a monoclonal system. Quinizarin is a highly fluorescent substance. The fact that it is almost insoluble in water significantly complicates the application of Raman spectroscopy in its study. However, infrared FT Raman and surface-enhanced Raman spectroscopy can also be used to characterize it in aqueous media [<xref rid="B188-molecules-25-05666" ref-type="bibr">188</xref>]. </p><p>Quinizarin is the simplest model molecule of a chromophore typical of some biologically and pharmaceutically significant compounds, including the antitumor anthracycline antibiotics doxorubicin, daunorubicin, and adriamycin, which are used in antineoplastic therapy. The quinizarin-like quinoid moiety is probably responsible for the cytotoxicity and cardiotoxicity of anthracycline drugs [<xref rid="B180-molecules-25-05666" ref-type="bibr">180</xref>]. It is thought to be able to intercalate into DNA [<xref rid="B189-molecules-25-05666" ref-type="bibr">189</xref>,<xref rid="B190-molecules-25-05666" ref-type="bibr">190</xref>]. We can classify it among the photosensitive intercalators with low hydrophobicity (AlogP = 2.324), which could be applied in PDT [<xref rid="B135-molecules-25-05666" ref-type="bibr">135</xref>]. The physical properties of quinizarin are shown in <xref rid="molecules-25-05666-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec6-molecules-25-05666"><title>6. Danthron</title><p>Danthron (1,8-dihydroxyanthraquinone or chrysazine, <xref ref-type="fig" rid="molecules-25-05666-f005">Figure 5</xref>) is a hydroxyanthraquinone that occurs wild in nature found in many plants but also in some insect species (e.g., <italic>Pyrrhalta luteola</italic> larvae). It is very often isolated from dry leaves and stems of the plant <italic>Xyris semifuscata</italic> growing in Madagascar [<xref rid="B191-molecules-25-05666" ref-type="bibr">191</xref>]. It is commercially available in the form of an orange, red, or red-yellow crystalline powder. Like quinizarin, it is soluble in basic solutions, chloroform, and DMSO. It is practically insoluble in water. Danthron and quinizarin are derivatives of emodin and hypericin. Danthron is part of the anticancer drug aclacinomycin. It is thought to intercalate into DNA and therefore can be used as an example of a low hydrophobicity intercalator (AlogP = 2.324) in PDT. However, it can also be a carcinogen, causing the development of adenoma or adenocarcinoma of the colon and increased incidence of liver cancer cells [<xref rid="B191-molecules-25-05666" ref-type="bibr">191</xref>,<xref rid="B192-molecules-25-05666" ref-type="bibr">192</xref>]. Danthron is one of the hydroxyanthraquinone derivatives causing topoisomerase II inhibition [<xref rid="B193-molecules-25-05666" ref-type="bibr">193</xref>], which is involved in various cellular processes, including chromosome segregation [<xref rid="B194-molecules-25-05666" ref-type="bibr">194</xref>], and it is essential for maintaining genome stability [<xref rid="B195-molecules-25-05666" ref-type="bibr">195</xref>].</p><p>Danthron is used as a laxative [<xref rid="B159-molecules-25-05666" ref-type="bibr">159</xref>,<xref rid="B196-molecules-25-05666" ref-type="bibr">196</xref>]. It is currently applied as an antioxidant, a fungicide to control powdery mildew, and has an irreplaceable role in the research into anticancer agents. Together with emodin, it is the basic structure of aglycones, which are naturally occurring laxative glycosides [<xref rid="B191-molecules-25-05666" ref-type="bibr">191</xref>]. Danthron shows mutagenic activity [<xref rid="B197-molecules-25-05666" ref-type="bibr">197</xref>] and indicates mutations in cells of the lymphatic system [<xref rid="B192-molecules-25-05666" ref-type="bibr">192</xref>].</p><p>Its structure has been studied using fluorescence, resonance Raman and infrared spectroscopy. The danthron crystal is tetragonal and its planar molecule has an asymmetric structure with two different intramolecular O&#x02026;..O distances. The optical properties of danthron can be discussed in terms of C<sub>2v</sub> pseudosymmetry [<xref rid="B188-molecules-25-05666" ref-type="bibr">188</xref>]. Danthron and quinizarin form two intramolecular hydrogen bonds, which cause small changes in the structure of anthraquinone molecules. The presence of two hydrogen bonds in quinizarin allows for double proton transfer, which can take place in two steps or a one-step process. Conversely, the geometry of the danthron molecule allows only single proton transmission. The structure of danthron and quinizarin has been intensively studied and experimentally determined. For quinizarin, X-ray structural analysis identified the values of the distance O&#x02026;..O and O&#x02026;..H bounds, which are 2.57 and 1.77&#x02013;1.79 &#x000c5; respectively. This technique helped to define the O&#x02026;..O distance for danthron and setting its value at 2.49 &#x000c5;, but it did not provide any information about proton binding [<xref rid="B198-molecules-25-05666" ref-type="bibr">198</xref>]. <xref rid="molecules-25-05666-t001" ref-type="table">Table 1</xref> shows characteristic physical properties.</p></sec><sec id="sec7-molecules-25-05666"><title>7. Hypericin and Its Derivatives Interaction with DNA</title><p>In recent years the interaction of hypericin, emodin, quinizarin, and danthron with biomacromolecules has been studied, especially with DNA, LDL, and human serum albumin (HSA) has been investigated [<xref rid="B199-molecules-25-05666" ref-type="bibr">199</xref>,<xref rid="B200-molecules-25-05666" ref-type="bibr">200</xref>,<xref rid="B201-molecules-25-05666" ref-type="bibr">201</xref>,<xref rid="B202-molecules-25-05666" ref-type="bibr">202</xref>]. The results of our studies in this area supplement the scientific knowledge on this subject. The measurements indicate that PSs incorporate into DNA, LDL, and HSA, but interact most easily with LDL particles. Distribution of molecules has been studied at two different conditions: (i) DNA&#x02013;ligand complexes were exposed to the presence of free LDL particles or HSA molecules, respectively and (ii) LDL&#x02013; or HSA&#x02013;ligand, respectively, complexes were in the presence of free DNA molecules. From measurements at the first conditions, it is clear that while the fluorescence intensity for the DNA-hypericin complex increases with the addition of LDL to the solution, a less pronounced effect can be observed for the other PSs, DNA&#x02013;emodin, DNA&#x02013;quinizarin, and DNA&#x02013;danthron. Similarly, HSA molecules added to the solution slightly increase the fluorescence intensity in the DNA&#x02013;hypericin complex. In a competitive environment, they redistribute and rebind from DNA macromolecule to LDL (hypericin) or HSA (emodin, quinizarin, and danthron). In contrast, the fluorescence intensity did not change for the DNA&#x02013;emodin complex, and a slight decrease in fluorescence has been observed in the DNA&#x02013;quinizarin and DNA&#x02013;dantron complexes. The presence of free DNA leads to a decrease in the fluorescence intensity of the LDL&#x02013;emodin, LDL&#x02013;quinizarin, and LDL&#x02013;danthron/HSA&#x02013;quinizarin and HSA&#x02013;danthron complexes. For LDL&#x02013;hypericin and HSA&#x02013;hypericin complexes, an increase in fluorescence with the addition of DNA was recorded. The fluorescence intensity of the HSA&#x02013;emodin complex remains unchanged [<xref rid="B135-molecules-25-05666" ref-type="bibr">135</xref>]. It is noteworthy that the quenching of fluorescence in the presence of DNA has been observed for intercalating molecules [<xref rid="B190-molecules-25-05666" ref-type="bibr">190</xref>]. These results allowed us to state that the molecules of the studied PSs can be extracted from DNA by HSA molecules rather than LDL particles, with the exception of hypericin, where there is a more significant binding from DNA in the presence of LDL particles. Experiments in fluorescence analysis of native and denatured DNA were designed to determine if and how the interaction of hypericin, emodin, quinizarin, and danthron with native and denatured DNA differed. Significant changes were detected for quinizarin and danthron, where fluorescence increased significantly in the presence of denatured DNA. It can be assumed that DNA denaturation increased the distances between the individual quinizarin and danthron molecules (there is a decrease in fluorescence quenching) and helped to better visualize the molecules inside the DNA. This applies in particular to molecules that intercalate into the DNA structure, i.e., quinizarin and danthron. For hypericin and emodin, it has been noted only a slight change in the intensity of fluorescence in the presence of denatured DNA, respectively from which it can again predict a different interaction mode of these PSs with DNA [<xref rid="B135-molecules-25-05666" ref-type="bibr">135</xref>].</p><p>As a representative of highly hydrophobic PSs, hypericin binds to DNA by means of a large groove [<xref rid="B203-molecules-25-05666" ref-type="bibr">203</xref>,<xref rid="B204-molecules-25-05666" ref-type="bibr">204</xref>]. A binding constant, whose value was also determined, is 4.0 &#x000d7; 10<sup>4</sup> L/mol [<xref rid="B204-molecules-25-05666" ref-type="bibr">204</xref>]. Emodin, with mild hydrophobic properties, interacts with DNA by binding into a small groove. This interaction is characterized by binding constant 8.1 &#x000d7; 10<sup>4</sup> L/mol. These ligands are incorporated into the DNA groove with hydrophobic or hydrogen bounds [<xref rid="B204-molecules-25-05666" ref-type="bibr">204</xref>]. An intercalating mode of interaction with DNA has been confirmed for quinizarin and danthron, which is very clearly supported by atomic force microscopy measurements. Quinizarin and dathron cause DNA to unwind due to intercalation, increasing the contour length of linear DNA by 10%. By the action of natural photosensitizers studied by us, more rigid molecules of linear DNA have been detected. It is known that this is not only the type of reaction they are involved in. Quinizarin and danthron can also bind to the surface of DNA molecules by means of electrostatic forces. The size of the binding constant of this interaction type for both PSs is 1.1 &#x000d7; 10<sup>4</sup> L/mol [<xref rid="B190-molecules-25-05666" ref-type="bibr">190</xref>].</p><p>Cell experiments have been performed with the aim of better understanding the mechanisms of the interaction of hypericin, emodin, quinizarin, and danthron with DNA. Success in the treatment of cancer requires sufficient hydrophobic drugs to cross the lipid membrane. The hydrophobicity of drugs therefore plays an important role in their distribution, metabolism, and excretion from the patient&#x000b4;s body. The main barrier preventing the interaction of nuclear DNA with anticancer drugs is the nuclear envelope. On the other hand, the detoxification process is accompanied by a decrease in drug concentration during the active outflow of these drugs. P-glycoprotein, a member of the transport protein family, is involved in this process [<xref rid="B205-molecules-25-05666" ref-type="bibr">205</xref>]. The function of these proteins is to remove toxins from cells [<xref rid="B206-molecules-25-05666" ref-type="bibr">206</xref>], so it is possible to regulate drug resistance by manipulating P-glycoprotein activity [<xref rid="B207-molecules-25-05666" ref-type="bibr">207</xref>,<xref rid="B208-molecules-25-05666" ref-type="bibr">208</xref>]. Another approach to preventing cancer cell resistance to drugs could be based on photochemical activation at a well-defined site/organelle [<xref rid="B209-molecules-25-05666" ref-type="bibr">209</xref>]. With this in mind, the intracellular interaction of the drugs discussed here with DNA directly in the nucleus was studied using selective photoactivation and regulation of P-glycoprotein function. Selective photoactivation facilitates entry of emodin, quinizarin, and danthron molecules into the nucleus of tumor cells by means of passive diffusion (this phenomenon has not been observed in the case of hypericin). Inhibition of P-glycoprotein may increase the intracellular concentration of the molecules studied and aid their interaction with DNA. Inhibition of P-glycoprotein stimulates the passive transport of these molecules to the nucleus of tumor cells. In addition, emodin is known to significantly promote the entry of other drugs into the nucleus of tumor cells, with the exception of strongly hydrophobic ones (hypericin-like), which are characterized by a high binding affinity for P-glycoprotein [<xref rid="B135-molecules-25-05666" ref-type="bibr">135</xref>].</p><p>The treatment of tumor cells with natural photosensitive drugs significantly depends on the degree of hydrophobicity, lipophilicity, and DNA intercalation properties of the drugs used. </p></sec><sec sec-type="conclusions" id="sec8-molecules-25-05666"><title>8. Conclusions</title><p>Cancer is a group of diseases characterized by abnormal and uncontrolled cell growth, which can affect a particular tissue or organ in a very aggressive manner and are able to spread to other parts of the body, they can metastasize. Cancer can be treated by classical therapeutic procedures (surgery, chemotherapy, and radiotherapy) and modern, very promising therapeutic methods. These include PDT. These studies show that the most effective way to treat cancer is to combine PDT with traditional therapies, respectively in some cases, PDT can even replace conventional treatment. It is very likely that PDT will be used in the future as the therapeutic approach in the treatment of specific cancers and non-cancerous diseases. This method minimizes the side effects of traditional therapeutic methods, is less invasive, more effective, and affordable. The condition for the successful treatment of cancer with PDT is the disruption of DNA macromolecule, which stops the division of tumor cells. Therefore, it is necessary to find suitable drugs that interact with DNA directly, respectively mediated by transporters that transport them to the nucleus of the tumor cell. A great advantage of newly discovered drugs is that they are natural, easier to prepare, and do not burden the patient&#x000b4;s body as much as synthetically produced drugs. The success of cancer treatment is highly dependent on the application of hydrophobic drugs, which can more easily cross the lipid membrane of tumor cells. Therefore, the interaction of drugs with different hydrophobicity with DNA macromolecule is the subject of many studies. </p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, J.S. and V.V.; methodology, J.B.; software, J.B.; validation, J.S., V.V. and J.B.; formal analysis, V.V.; investigation, V.V.; resources, V.V.; data curation, J.S.; writing&#x02014;original draft preparation, V.V.; writing&#x02014;review and editing, J.S.; visualization, J.B.; supervision, J.S.; project administration, J.S.; funding acquisition, J.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This study was supported by Slovak Research Grant Agency through KEGA project No. 012 UVLF-4/2018. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-05666"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castano</surname><given-names>A.P.</given-names></name><name><surname>Demidova</surname><given-names>T.N.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name></person-group><article-title>Mechanisms in photodynamic therapy: Part one&#x02014;photosensitizers, photochemistry and cellular localization</article-title><source>Photodiagnosis. Photodyn. Ther.</source><year>2004</year><volume>1</volume><fpage>279</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/S1572-1000(05)00007-4</pub-id><pub-id pub-id-type="pmid">25048432</pub-id></element-citation></ref><ref id="B2-molecules-25-05666"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deda</surname><given-names>D.K.</given-names></name><name><surname>Araki</surname><given-names>K.</given-names></name></person-group><article-title>Nanotechnology, light and chemical action: An effective combination to kill cancer cells</article-title><source>J. Braz. Chem. Soc.</source><year>2015</year><volume>26</volume><fpage>2448</fpage><lpage>2470</lpage><pub-id pub-id-type="doi">10.5935/0103-5053.20150316</pub-id></element-citation></ref><ref id="B3-molecules-25-05666"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>T.M.</given-names></name><name><surname>Hansen</surname><given-names>C.B.</given-names></name><name><surname>Demenzes</surname><given-names>D.E.L.</given-names></name></person-group><article-title>Pharmacokinetics of long circulating liposomes</article-title><source>Adv. Drug Deliv. Rev.</source><year>1995</year><volume>16</volume><fpage>267</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1016/0169-409X(95)00029-7</pub-id></element-citation></ref><ref id="B4-molecules-25-05666"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loomis</surname><given-names>K.</given-names></name><name><surname>McNeeley</surname><given-names>K.</given-names></name><name><surname>Bellamkonda</surname><given-names>R.V.</given-names></name></person-group><article-title>Nanoparticles with targeting triggered release and imaging functionality for cancer application</article-title><source>Soft. Matter.</source><year>2011</year><volume>7</volume><fpage>839</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1039/C0SM00534G</pub-id></element-citation></ref><ref id="B5-molecules-25-05666"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddi</surname><given-names>E.</given-names></name></person-group><article-title>Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumors</article-title><source>J. Photochem. Photobiol. B</source><year>1997</year><volume>37</volume><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/S1011-1344(96)07404-0</pub-id><pub-id pub-id-type="pmid">9085566</pub-id></element-citation></ref><ref id="B6-molecules-25-05666"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunto&#x00161;ov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Buzov&#x000e1;</surname><given-names>D.</given-names></name><name><surname>Petrovajov&#x000e1;</surname><given-names>D.</given-names></name><name><surname>Kasak</surname><given-names>P.</given-names></name><name><surname>Na&#x0010f;ov&#x000e1;</surname><given-names>Z.</given-names></name><name><surname>Jancura</surname><given-names>D.</given-names></name><name><surname>Sureau</surname><given-names>F.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name></person-group><article-title>Development of a new LDL-based transport system for hydrophobic/amphiphilic drug delivery to cancer cells</article-title><source>Int. J. Pharm.</source><year>2012</year><volume>436</volume><fpage>463</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2012.07.005</pub-id><pub-id pub-id-type="pmid">22814227</pub-id></element-citation></ref><ref id="B7-molecules-25-05666"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hally</surname><given-names>C.</given-names></name><name><surname>Delcanale</surname><given-names>P.</given-names></name><name><surname>Nonell</surname><given-names>S.</given-names></name><name><surname>Viappiani</surname><given-names>C.</given-names></name><name><surname>Abbruzzetti</surname><given-names>S.</given-names></name></person-group><article-title>Photosensitizing proteins for antibacterial photodynamic inactivation</article-title><source>Transl. Biophotonics</source><year>2020</year><fpage>e201900031</fpage><pub-id pub-id-type="doi">10.1002/tbio.201900031</pub-id></element-citation></ref><ref id="B8-molecules-25-05666"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghorbani</surname><given-names>J.</given-names></name><name><surname>Rahban</surname><given-names>D.</given-names></name><name><surname>Aghamiri</surname><given-names>S.</given-names></name><name><surname>Teymouri</surname><given-names>A.</given-names></name><name><surname>Bahador</surname><given-names>A.</given-names></name></person-group><article-title>Photosensitizers in antibacterial photodynamic therapy: An overview</article-title><source>Laser Ther.</source><year>2018</year><volume>27</volume><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.5978/islsm.27_18-RA-01</pub-id><?supplied-pmid 31182904?><pub-id pub-id-type="pmid">31182904</pub-id></element-citation></ref><ref id="B9-molecules-25-05666"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buriankova</surname><given-names>L.</given-names></name><name><surname>Buzova</surname><given-names>D.</given-names></name><name><surname>Chorvat</surname><given-names>D.</given-names></name><name><surname>Sureau</surname><given-names>F.</given-names></name><name><surname>Brault</surname><given-names>D.</given-names></name><name><surname>Miskovsky</surname><given-names>P.</given-names></name><name><surname>Jancura</surname><given-names>D.</given-names></name></person-group><article-title>Kinetics of hypericin association with low-density lipoproteins</article-title><source>Photochem. Photobiol.</source><year>2011</year><volume>87</volume><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.2010.00847.x</pub-id><pub-id pub-id-type="pmid">21114669</pub-id></element-citation></ref><ref id="B10-molecules-25-05666"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenkavska</surname><given-names>L.</given-names></name><name><surname>Blascakova</surname><given-names>L.</given-names></name><name><surname>Jurasekova</surname><given-names>Z.</given-names></name><name><surname>Macajova</surname><given-names>M.</given-names></name><name><surname>Bilcik</surname><given-names>B.</given-names></name><name><surname>Cavarga</surname><given-names>I.</given-names></name><name><surname>Miskovsky</surname><given-names>P.</given-names></name><name><surname>Huntosova</surname><given-names>V.</given-names></name></person-group><article-title>Benefits of hypericin transport and delivery by low- and high-density lipoproteins to cancer cells: From in vitro to ex ovo</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2019</year><volume>25</volume><fpage>214</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2018.12.013</pub-id><pub-id pub-id-type="pmid">30597213</pub-id></element-citation></ref><ref id="B11-molecules-25-05666"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konan</surname><given-names>Y.N.</given-names></name><name><surname>Gurny</surname><given-names>R.</given-names></name><name><surname>Allemann</surname><given-names>E.</given-names></name></person-group><article-title>State of the art in the delivery of photosensitizers for photodynamic therapy</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2002</year><volume>66</volume><fpage>89</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/S1011-1344(01)00267-6</pub-id></element-citation></ref><ref id="B12-molecules-25-05666"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firestone</surname><given-names>R.A.</given-names></name></person-group><article-title>Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells</article-title><source>Bioconjugate Chem.</source><year>1994</year><volume>5</volume><fpage>105</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1021/bc00026a002</pub-id><?supplied-pmid 8031872?><pub-id pub-id-type="pmid">8031872</pub-id></element-citation></ref><ref id="B13-molecules-25-05666"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Versluis</surname><given-names>A.J.</given-names></name><name><surname>van Geel</surname><given-names>P.J.</given-names></name><name><surname>Oppellar</surname><given-names>H.</given-names></name><name><surname>van Berkel</surname><given-names>T.J.</given-names></name><name><surname>Bijsterbosch</surname><given-names>M.K.</given-names></name></person-group><article-title>Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice</article-title><source>Br. J. Cancer</source><year>1996</year><volume>4</volume><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1038/bjc.1996.396</pub-id><?supplied-pmid 8761365?><pub-id pub-id-type="pmid">8761365</pub-id></element-citation></ref><ref id="B14-molecules-25-05666"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rensen</surname><given-names>P.C.</given-names></name><name><surname>de Vrueh</surname><given-names>R.L.</given-names></name><name><surname>Kuiper</surname><given-names>J.</given-names></name><name><surname>Bijsterbosch</surname><given-names>M.K.</given-names></name><name><surname>Biessen</surname><given-names>E.A.</given-names></name><name><surname>van Berkel</surname><given-names>T.J.</given-names></name></person-group><article-title>Recombinant lipoproteins: Lipoprotein-like lipid particles for drug targeting</article-title><source>Adv. Drug Deliv. Rev.</source><year>2001</year><volume>47</volume><fpage>251</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/S0169-409X(01)00109-0</pub-id><pub-id pub-id-type="pmid">11311995</pub-id></element-citation></ref><ref id="B15-molecules-25-05666"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kader</surname><given-names>A.</given-names></name><name><surname>Pater.</surname><given-names>A.</given-names></name></person-group><article-title>Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells</article-title><source>J. Control. Release</source><year>2002</year><volume>80</volume><fpage>29</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S0168-3659(01)00536-3</pub-id><pub-id pub-id-type="pmid">11943385</pub-id></element-citation></ref><ref id="B16-molecules-25-05666"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>G.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Glickson</surname><given-names>J.D.</given-names></name></person-group><article-title>Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>17757</fpage><lpage>17762</lpage><pub-id pub-id-type="doi">10.1073/pnas.0508677102</pub-id><pub-id pub-id-type="pmid">16306263</pub-id></element-citation></ref><ref id="B17-molecules-25-05666"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Sunar</surname><given-names>U.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Corbin</surname><given-names>I.</given-names></name><name><surname>Yodh</surname><given-names>A.G.</given-names></name><name><surname>Zheng</surname><given-names>G.</given-names></name></person-group><article-title>Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment</article-title><source>Int. J. Nanomed.</source><year>2007</year><volume>2</volume><fpage>767</fpage><lpage>774</lpage></element-citation></ref><ref id="B18-molecules-25-05666"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>T.J.</given-names></name><name><surname>Gomer</surname><given-names>C.J.</given-names></name><name><surname>Henderson</surname><given-names>B.W.</given-names></name><name><surname>Jori</surname><given-names>G.</given-names></name><name><surname>Kessel</surname><given-names>D.</given-names></name><name><surname>Korbelik</surname><given-names>M.</given-names></name><name><surname>Moan</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>Q.</given-names></name></person-group><article-title>Photodynamic therapy</article-title><source>J. Natl. Cancer Inst.</source><year>1998</year><volume>90</volume><fpage>889</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1093/jnci/90.12.889</pub-id><pub-id pub-id-type="pmid">9637138</pub-id></element-citation></ref><ref id="B19-molecules-25-05666"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>B.C.</given-names></name><name><surname>Patterson</surname><given-names>M.S.</given-names></name></person-group><article-title>The physics, biophysics and technology of photodynamic therapy</article-title><source>Phys. Med. Biol.</source><year>2008</year><volume>53</volume><fpage>R61</fpage><lpage>R109</lpage><pub-id pub-id-type="doi">10.1088/0031-9155/53/9/R01</pub-id><pub-id pub-id-type="pmid">18401068</pub-id></element-citation></ref><ref id="B20-molecules-25-05666"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>S.</given-names></name><name><surname>Hirohara</surname><given-names>S.</given-names></name><name><surname>Obata</surname><given-names>M.</given-names></name><name><surname>Hagiya</surname><given-names>Y.</given-names></name><name><surname>Ogura</surname><given-names>S.</given-names></name><name><surname>Ikeda</surname><given-names>A.</given-names></name><name><surname>Kataoka</surname><given-names>H.</given-names></name><name><surname>Tanaka</surname><given-names>M.</given-names></name><name><surname>Joh</surname><given-names>T.</given-names></name></person-group><article-title>Current states and future views in photodynamic therapy</article-title><source>J. Photochem. Photobiol. C Photochem. Rev.</source><year>2011</year><volume>12</volume><fpage>46</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.jphotochemrev.2011.06.001</pub-id></element-citation></ref><ref id="B21-molecules-25-05666"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>C.K.</given-names></name><name><surname>Heo</surname><given-names>J.</given-names></name><name><surname>Shin</surname><given-names>S.</given-names></name><name><surname>Jeong</surname><given-names>K.</given-names></name><name><surname>Seo</surname><given-names>Y.H.</given-names></name><name><surname>Jang</surname><given-names>W.D.</given-names></name><name><surname>Park</surname><given-names>C.R.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Kwon</surname><given-names>I.C.</given-names></name></person-group><article-title>Nanophotosensitizers toward advanced photodynamic therapy of cancer</article-title><source>Cancer Lett.</source><year>2013</year><volume>334</volume><fpage>176</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2012.09.012</pub-id><?supplied-pmid 23017942?><pub-id pub-id-type="pmid">23017942</pub-id></element-citation></ref><ref id="B22-molecules-25-05666"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bechet</surname><given-names>D.</given-names></name><name><surname>Mordon</surname><given-names>S.R.</given-names></name><name><surname>Guillemin</surname><given-names>F.</given-names></name><name><surname>Barberi-Heyob</surname><given-names>M.A.</given-names></name></person-group><article-title>Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies</article-title><source>Cancer Treat. Rev.</source><year>2014</year><volume>40</volume><fpage>229</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.ctrv.2012.07.004</pub-id><?supplied-pmid 22858248?><pub-id pub-id-type="pmid">22858248</pub-id></element-citation></ref><ref id="B23-molecules-25-05666"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benov</surname><given-names>L.</given-names></name></person-group><article-title>Photodynamic therapy: Current status and future direction</article-title><source>Med. Princ. Pract.</source><year>2015</year><volume>24</volume><fpage>14</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1159/000362416</pub-id><?supplied-pmid 24820409?><pub-id pub-id-type="pmid">24820409</pub-id></element-citation></ref><ref id="B24-molecules-25-05666"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miguel-Gomez</surname><given-names>L.</given-names></name><name><surname>Vano-Galvan</surname><given-names>S.</given-names></name><name><surname>Perez-Garcia</surname><given-names>B.</given-names></name><name><surname>Carrillo-Gijon</surname><given-names>R.</given-names></name><name><surname>Jaen-Olasolo</surname><given-names>P.</given-names></name></person-group><article-title>Treatment of folliculitis decalvans with photodynamic therapy: Results in 10 patients</article-title><source>J. Am. Acad. Dermatol.</source><year>2015</year><volume>72</volume><fpage>1085</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2015.02.1120</pub-id><pub-id pub-id-type="pmid">25981008</pub-id></element-citation></ref><ref id="B25-molecules-25-05666"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharman</surname><given-names>W.M.</given-names></name><name><surname>Allen</surname><given-names>C.M.</given-names></name><name><surname>van Lier</surname><given-names>J.E.</given-names></name></person-group><article-title>Photodynamic therapeutics: Basic principles and clinical applications</article-title><source>Drug Discov. Today</source><year>1999</year><volume>4</volume><fpage>507</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1016/S1359-6446(99)01412-9</pub-id><pub-id pub-id-type="pmid">10529768</pub-id></element-citation></ref><ref id="B26-molecules-25-05666"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Kang</surname><given-names>H.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name></person-group><article-title>Nanostructures of an amphiphilic zinc phthalocyanine polymer conjugate for photodynamic therapy of psoriasis</article-title><source>Colloids Surf. B</source><year>2015</year><volume>128</volume><fpage>405</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2015.02.038</pub-id></element-citation></ref><ref id="B27-molecules-25-05666"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharman</surname><given-names>W.M.</given-names></name><name><surname>van Lier</surname><given-names>J.E.</given-names></name><name><surname>Allen</surname><given-names>C.M.</given-names></name></person-group><article-title>Targeted photodynamic theory via receptor mediated delivery systems</article-title><source>Adv. Drug Deliv. Rev.</source><year>2004</year><volume>56</volume><fpage>53</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2003.08.015</pub-id><pub-id pub-id-type="pmid">14706445</pub-id></element-citation></ref><ref id="B28-molecules-25-05666"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruess</surname><given-names>A.F.</given-names></name><name><surname>Zlateva</surname><given-names>G.</given-names></name><name><surname>Pleil</surname><given-names>A.M.</given-names></name><name><surname>Wirostko</surname><given-names>B.</given-names></name></person-group><article-title>Photodynamic therapy with verteporfin in age-related macular degeneration: A systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties</article-title><source>Acta Ophthalmol.</source><year>2009</year><volume>87</volume><fpage>118</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1111/j.1755-3768.2008.01218.x</pub-id><pub-id pub-id-type="pmid">18577193</pub-id></element-citation></ref><ref id="B29-molecules-25-05666"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rockson</surname><given-names>S.G.</given-names></name><name><surname>Lorenz</surname><given-names>D.P.</given-names></name><name><surname>Cheong</surname><given-names>W.F.</given-names></name><name><surname>Woodburn</surname><given-names>K.W.</given-names></name></person-group><article-title>Photoangioplasty: An emerging clinical cardiovascular role for photodynamic therapy</article-title><source>Circulation</source><year>2000</year><volume>102</volume><fpage>591</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.102.5.591</pub-id><pub-id pub-id-type="pmid">10920074</pub-id></element-citation></ref><ref id="B30-molecules-25-05666"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozzini</surname><given-names>G.</given-names></name><name><surname>Colin</surname><given-names>P.</given-names></name><name><surname>Betrouni</surname><given-names>N.</given-names></name><name><surname>Nevoux</surname><given-names>P.</given-names></name><name><surname>Ouzzane</surname><given-names>A.</given-names></name><name><surname>Puech</surname><given-names>P.</given-names></name><name><surname>Willers</surname><given-names>A.</given-names></name><name><surname>Mordon</surname><given-names>S.</given-names></name></person-group><article-title>Photodynamic therapy in urology: What can we do now and where are we heading</article-title><source>Photodiagn. Photodyn. Ther.</source><year>2012</year><volume>9</volume><fpage>261</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2012.01.005</pub-id></element-citation></ref><ref id="B31-molecules-25-05666"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panzarini</surname><given-names>E.</given-names></name><name><surname>Inguscio</surname><given-names>V.</given-names></name><name><surname>Dini</surname><given-names>L.</given-names></name></person-group><article-title>Immunogenic cell death: Can it be exploited in photodynamic therapy for cancer</article-title><source>Biomed. Res. Int.</source><year>2013</year><volume>2013</volume><fpage>482160</fpage><pub-id pub-id-type="doi">10.1155/2013/482160</pub-id><?supplied-pmid 23509727?><pub-id pub-id-type="pmid">23509727</pub-id></element-citation></ref><ref id="B32-molecules-25-05666"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>G.E.</given-names></name><name><surname>Mennel</surname><given-names>S.</given-names></name><name><surname>Spital</surname><given-names>G.</given-names></name><name><surname>Wachtlin</surname><given-names>J.</given-names></name><name><surname>Jurklies</surname><given-names>B.</given-names></name><name><surname>Heimann</surname><given-names>H.</given-names></name><name><surname>Damato</surname><given-names>B.</given-names></name><name><surname>Meyer</surname><given-names>C.H.</given-names></name></person-group><article-title>Different indications of photodynamic therapy in ophthalmology</article-title><source>Klin. Monbl. Augenheilkd.</source><year>2009</year><volume>226</volume><fpage>725</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1055/s-0028-1109514</pub-id><?supplied-pmid 19603375?><pub-id pub-id-type="pmid">19603375</pub-id></element-citation></ref><ref id="B33-molecules-25-05666"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trindade</surname><given-names>A.C.</given-names></name><name><surname>De Figueiredo</surname><given-names>J.A.P.</given-names></name><name><surname>Steier</surname><given-names>L.</given-names></name><name><surname>Weber</surname><given-names>J.B.B.</given-names></name></person-group><article-title>Photodynamic therapy in endodontics: A literature review</article-title><source>Photomed. Laser Surg.</source><year>2015</year><volume>33</volume><fpage>175</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1089/pho.2014.3776</pub-id><?supplied-pmid 25719896?><pub-id pub-id-type="pmid">25719896</pub-id></element-citation></ref><ref id="B34-molecules-25-05666"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vohra</surname><given-names>F.</given-names></name><name><surname>Al-Kheraif</surname><given-names>A.A.</given-names></name><name><surname>Qadri</surname><given-names>T.</given-names></name><name><surname>Hassan</surname><given-names>M.I.A.</given-names></name><name><surname>Ahmedef</surname><given-names>A.</given-names></name><name><surname>Warnakulasuriya</surname><given-names>S.</given-names></name><name><surname>Javed</surname><given-names>F.</given-names></name></person-group><article-title>Efficacy of photodynamic therapy in the management of oral premalignant lesions. A systematic review</article-title><source>Photodiagn. Photodyn. Ther.</source><year>2015</year><volume>12</volume><fpage>150</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2014.10.001</pub-id></element-citation></ref><ref id="B35-molecules-25-05666"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karrer</surname><given-names>S.</given-names></name><name><surname>Kohl</surname><given-names>E.</given-names></name><name><surname>Feise</surname><given-names>K.</given-names></name><name><surname>Hiepe-Wegener</surname><given-names>D.</given-names></name><name><surname>Lischner</surname><given-names>S.</given-names></name><name><surname>Philipp-Dormston</surname><given-names>W.</given-names></name><name><surname>Podda</surname><given-names>M.</given-names></name><name><surname>Prager</surname><given-names>W.</given-names></name><name><surname>Walker</surname><given-names>T.</given-names></name><name><surname>Szeimies</surname><given-names>R.M.</given-names></name></person-group><article-title>Photodynamic therapy for skin rejuvenation: Review and summary of the literature-results of a consensus conference of an expert group for aesthetic photodynamic therapy</article-title><source>J. Dtsch. Dermatol. Ges.</source><year>2013</year><volume>11</volume><fpage>137</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1111/j.1610-0387.2012.08046.x</pub-id><pub-id pub-id-type="pmid">23190505</pub-id></element-citation></ref><ref id="B36-molecules-25-05666"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrmann</surname><given-names>G.</given-names></name><name><surname>Serio</surname><given-names>A.</given-names></name><name><surname>Mazo</surname><given-names>M.</given-names></name><name><surname>Nair</surname><given-names>R.</given-names></name><name><surname>Stevens</surname><given-names>M.M.</given-names></name></person-group><article-title>Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins</article-title><source>J. Control. Release</source><year>2015</year><volume>205</volume><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2014.11.029</pub-id><pub-id pub-id-type="pmid">25483424</pub-id></element-citation></ref><ref id="B37-molecules-25-05666"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baptista</surname><given-names>M.S.</given-names></name><name><surname>Wainwright</surname><given-names>M.</given-names></name></person-group><article-title>Photodynamic antimicrobial chemotherapy (PACT) for the treatment of malaria, leishmaniasis and trypanosomiasis</article-title><source>Braz. J. Med. Res.</source><year>2011</year><volume>44</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2010007500141</pub-id></element-citation></ref><ref id="B38-molecules-25-05666"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goslinski</surname><given-names>T.</given-names></name><name><surname>Piskorz</surname><given-names>J.</given-names></name></person-group><article-title>Fluorinated porphyrinoids and their biomedical applications</article-title><source>J. Photochem. Photobiol. C Photochem. Rev.</source><year>2011</year><volume>12</volume><fpage>304</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/j.jphotochemrev.2011.09.005</pub-id></element-citation></ref><ref id="B39-molecules-25-05666"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanakova</surname><given-names>A.</given-names></name><name><surname>Bogdanova</surname><given-names>K.</given-names></name><name><surname>Tomankova</surname><given-names>K.</given-names></name><name><surname>Pizova</surname><given-names>K.</given-names></name><name><surname>Malohlava</surname><given-names>J.</given-names></name><name><surname>Binder</surname><given-names>S.</given-names></name><name><surname>Bajgar</surname><given-names>R.</given-names></name><name><surname>Langova</surname><given-names>K.</given-names></name><name><surname>Kolar</surname><given-names>M.</given-names></name><name><surname>Mosinger</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The application of antimicrobial photodynamic therapy on S. aureus and E. coli using porphyrin photosensitizers bound to cyclodextrin</article-title><source>Microbiol. Res.</source><year>2014</year><volume>169</volume><fpage>163</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2013.07.005</pub-id><pub-id pub-id-type="pmid">23899404</pub-id></element-citation></ref><ref id="B40-molecules-25-05666"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltazar</surname><given-names>L.M.</given-names></name><name><surname>Ray</surname><given-names>A.</given-names></name><name><surname>Santos</surname><given-names>D.A.</given-names></name><name><surname>Cisalpino</surname><given-names>P.S.</given-names></name><name><surname>Friedman</surname><given-names>A.J.</given-names></name><name><surname>Nosanchuk</surname><given-names>J.D.</given-names></name></person-group><article-title>Antimicrobial photodynamic therapy: An effective alternative approach to control fungal injections</article-title><source>Front. Microbiol.</source><year>2015</year><volume>6</volume><fpage>202</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00202</pub-id><pub-id pub-id-type="pmid">25821448</pub-id></element-citation></ref><ref id="B41-molecules-25-05666"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnett</surname><given-names>R.</given-names></name></person-group><article-title>Progress with heterocyclic photosensitizers for the photodynamic therapy (PDT) of tomours</article-title><source>J. Heterocyclic Chem.</source><year>2002</year><volume>39</volume><fpage>455</fpage><pub-id pub-id-type="doi">10.1002/jhet.5570390303</pub-id></element-citation></ref><ref id="B42-molecules-25-05666"><label>42.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>Photolitec, LLC</collab></person-group><article-title>Tumor Specific Imaging Therapy</article-title><source>Photodynamic Therapy.</source><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://photolitec.org/Tech_PDT.html">http://photolitec.org/Tech_PDT.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-08-10">(accessed on 10 August 2020)</date-in-citation></element-citation></ref><ref id="B43-molecules-25-05666"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vatansever</surname><given-names>F.</given-names></name><name><surname>de Melo</surname><given-names>W.C.M.A.</given-names></name><name><surname>Avci</surname><given-names>P.</given-names></name><name><surname>Vecchio</surname><given-names>D.</given-names></name><name><surname>Sadasivam</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Chandran</surname><given-names>R.</given-names></name><name><surname>Karimi</surname><given-names>M.</given-names></name><name><surname>Parizotto</surname><given-names>N.A.</given-names></name><name><surname>Yin</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Antimicrobial strategies centered around reactive oxygen species&#x02014;bactericidal antibiotics, photodynamic therapy, and beyond</article-title><source>Microbiol. Rev.</source><year>2013</year><volume>37</volume><fpage>955</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1111/1574-6976.12026</pub-id><?supplied-pmid 23802986?><pub-id pub-id-type="pmid">23802986</pub-id></element-citation></ref><ref id="B44-molecules-25-05666"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>B.W.</given-names></name><name><surname>Dougherty</surname><given-names>T.J.</given-names></name></person-group><article-title>How does photodynamic therapy work</article-title><source>Photochem. Photobiol.</source><year>1992</year><volume>55</volume><fpage>145</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1992.tb04222.x</pub-id><pub-id pub-id-type="pmid">1603846</pub-id></element-citation></ref><ref id="B45-molecules-25-05666"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostinis</surname><given-names>P.</given-names></name><name><surname>Berg</surname><given-names>K.</given-names></name><name><surname>Cengel</surname><given-names>K.A.</given-names></name><name><surname>Foster</surname><given-names>T.H.</given-names></name><name><surname>Girotti</surname><given-names>A.W.</given-names></name><name><surname>Gollnick</surname><given-names>S.O.</given-names></name><name><surname>Hahn</surname><given-names>S.M.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name><name><surname>Juzeniene</surname><given-names>A.</given-names></name><name><surname>Kessel</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Photodynamic therapy of cancer: An update</article-title><source>CA Cancer J. Clin.</source><year>2011</year><volume>61</volume><fpage>250</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.3322/caac.20114</pub-id><?supplied-pmid 21617154?><pub-id pub-id-type="pmid">21617154</pub-id></element-citation></ref><ref id="B46-molecules-25-05666"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senapathy</surname><given-names>G.J.</given-names></name><name><surname>George</surname><given-names>B.P.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>Exloring the role of phytochemicals as potent natural photosensitizers in photodynamic therapy</article-title><source>Anticancer Agents Med. Chem.</source><year>2020</year><volume>20</volume><fpage>1831</fpage><lpage>1844</lpage><pub-id pub-id-type="doi">10.2174/1871520620666200703192127</pub-id><?supplied-pmid 32619181?><pub-id pub-id-type="pmid">32619181</pub-id></element-citation></ref><ref id="B47-molecules-25-05666"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moan</surname><given-names>J.</given-names></name><name><surname>Berg</surname><given-names>K.</given-names></name></person-group><article-title>The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen</article-title><source>Photochem. Photobiol.</source><year>1991</year><volume>53</volume><fpage>549</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1991.tb03669.x</pub-id><pub-id pub-id-type="pmid">1830395</pub-id></element-citation></ref><ref id="B48-molecules-25-05666"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatz</surname><given-names>S.</given-names></name><name><surname>Poulsen</surname><given-names>L.</given-names></name><name><surname>Ogilby</surname><given-names>P.R.</given-names></name></person-group><article-title>Time-resolved singlet oxygen phosphorescence measurements from photosensitized experiments in single cells: Effects of oxygen diffusion and oxygen concentration</article-title><source>Photochem. Photobiol.</source><year>2008</year><volume>84</volume><fpage>1284</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.2008.00359.x</pub-id><pub-id pub-id-type="pmid">18435700</pub-id></element-citation></ref><ref id="B49-molecules-25-05666"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyst</surname><given-names>H.J.</given-names></name><name><surname>Tan</surname><given-names>I.B.</given-names></name><name><surname>Stewart</surname><given-names>F.A.</given-names></name><name><surname>Balm</surname><given-names>A.J.M.</given-names></name></person-group><article-title>Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2009</year><volume>6</volume><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2009.03.002</pub-id><pub-id pub-id-type="pmid">19447366</pub-id></element-citation></ref><ref id="B50-molecules-25-05666"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>M.</given-names></name></person-group><article-title>High sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen</article-title><source>Int. J. Radiat. Biol.</source><year>1998</year><volume>74</volume><fpage>249</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1080/095530098141636</pub-id><pub-id pub-id-type="pmid">9712554</pub-id></element-citation></ref><ref id="B51-molecules-25-05666"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochevar</surname><given-names>I.E.</given-names></name><name><surname>Lambert</surname><given-names>C.R.</given-names></name><name><surname>Lynch</surname><given-names>M.C.</given-names></name><name><surname>Tedesco</surname><given-names>A.C.</given-names></name></person-group><article-title>Comparison of photosensitized plasma membrane damage caused by singlet oxygen and free radicals</article-title><source>Biochim. Biophys. Acta</source><year>1996</year><volume>1280</volume><fpage>223</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1016/0005-2736(95)00297-9</pub-id><pub-id pub-id-type="pmid">8639697</pub-id></element-citation></ref><ref id="B52-molecules-25-05666"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>H.</given-names></name><name><surname>Tralau</surname><given-names>C.J.</given-names></name><name><surname>Boulos</surname><given-names>P.B.</given-names></name><name><surname>MacRobert</surname><given-names>A.J.</given-names></name><name><surname>Tilly</surname><given-names>R.</given-names></name><name><surname>Bown</surname><given-names>S.G.</given-names></name></person-group><article-title>The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury</article-title><source>Photochem. Photobiol.</source><year>1987</year><volume>46</volume><fpage>795</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1987.tb04850.x</pub-id><?supplied-pmid 3441502?><pub-id pub-id-type="pmid">3441502</pub-id></element-citation></ref><ref id="B53-molecules-25-05666"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopper</surname><given-names>C.</given-names></name></person-group><article-title>Photodynamic therapy. A clinical reality in the treatment of cancer</article-title><source>Lancet. Oncol.</source><year>2000</year><volume>1</volume><fpage>212</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(00)00166-2</pub-id><pub-id pub-id-type="pmid">11905638</pub-id></element-citation></ref><ref id="B54-molecules-25-05666"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>R.R.</given-names></name><name><surname>Bagnato</surname><given-names>V.S.</given-names></name><name><surname>Sibata</surname><given-names>C.H.</given-names></name></person-group><article-title>Future of oncologic photodynamic therapy</article-title><source>Future Oncol.</source><year>2010</year><volume>6</volume><fpage>929</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.2217/fon.10.51</pub-id><?supplied-pmid 20528231?><pub-id pub-id-type="pmid">20528231</pub-id></element-citation></ref><ref id="B55-molecules-25-05666"><label>55.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Foote</surname><given-names>C.</given-names></name></person-group><article-title>Mechanisms of photo-oxygenation</article-title><source>Porphyrin Localization and Treatment of Tumors</source><edition>1st ed.</edition><person-group person-group-type="editor"><name><surname>Doiron</surname><given-names>D.R.</given-names></name><name><surname>Gomer</surname><given-names>C.J.</given-names></name></person-group><publisher-name>Alan R. Liss</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1984</year><fpage>3</fpage><lpage>18</lpage></element-citation></ref><ref id="B56-molecules-25-05666"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boegheim</surname><given-names>J.P.</given-names></name><name><surname>Scholte</surname><given-names>H.</given-names></name><name><surname>Dubbehman</surname><given-names>T.M.</given-names></name><name><surname>Beems</surname><given-names>E.</given-names></name><name><surname>Raap</surname><given-names>A.K.</given-names></name><name><surname>van Steveninck</surname><given-names>J.</given-names></name></person-group><article-title>Photodynamic effects of hematoporphyrin-derivative on enzyme activities of murine L929 fibroblasts</article-title><source>J. Photochem. Photobiol. B</source><year>1987</year><volume>1</volume><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/1011-1344(87)80006-4</pub-id><pub-id pub-id-type="pmid">2977616</pub-id></element-citation></ref><ref id="B57-molecules-25-05666"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>S.L.</given-names></name><name><surname>Hilf</surname><given-names>R.</given-names></name></person-group><article-title>Interdependence of fluence, drug, dose and oxygen on hematoporphyrin derivate induced photosensitization of tumor mitochondria</article-title><source>Photochem. Photobiol.</source><year>1985</year><volume>42</volume><fpage>367</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1985.tb01583.x</pub-id><pub-id pub-id-type="pmid">3003767</pub-id></element-citation></ref><ref id="B58-molecules-25-05666"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolmans</surname><given-names>D.E.</given-names></name><name><surname>Fukumura</surname><given-names>D.</given-names></name><name><surname>Jain</surname><given-names>R.K.</given-names></name></person-group><article-title>Photodynamic therapy for cancer</article-title><source>Nat. Rev. Cancer</source><year>2003</year><volume>3</volume><fpage>380</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1038/nrc1071</pub-id><pub-id pub-id-type="pmid">12724736</pub-id></element-citation></ref><ref id="B59-molecules-25-05666"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochsner</surname><given-names>M.</given-names></name></person-group><article-title>Photophysical and photobiological processes in the photodynamic therapy of tumors</article-title><source>J. Photochem. Photobiol. B</source><year>1997</year><volume>39</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/S1011-1344(96)07428-3</pub-id><pub-id pub-id-type="pmid">9210318</pub-id></element-citation></ref><ref id="B60-molecules-25-05666"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canti</surname><given-names>G.</given-names></name><name><surname>Lattuada</surname><given-names>D.</given-names></name><name><surname>Morelli</surname><given-names>S.</given-names></name><name><surname>Nicolin</surname><given-names>A.</given-names></name><name><surname>Cubeddu</surname><given-names>R.</given-names></name><name><surname>Taroni</surname><given-names>P.</given-names></name><name><surname>Valentini</surname><given-names>G.</given-names></name></person-group><article-title>Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors</article-title><source>Cancer Lett.</source><year>1995</year><volume>93</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/0304-3835(95)03818-H</pub-id><pub-id pub-id-type="pmid">7621437</pub-id></element-citation></ref><ref id="B61-molecules-25-05666"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lofgren</surname><given-names>L.A.</given-names></name><name><surname>Hallgren</surname><given-names>S.</given-names></name><name><surname>Nilsson</surname><given-names>E.</given-names></name><name><surname>Westerborn</surname><given-names>A.</given-names></name><name><surname>Nilsson</surname><given-names>C.</given-names></name><name><surname>Reizenstein</surname><given-names>J.</given-names></name></person-group><article-title>photodynamic therapy for recurrent nasopharyngeal cancer</article-title><source>Arch. Otolaryngol. Head Neck Surg.</source><year>1995</year><volume>121</volume><fpage>997</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1001/archotol.1995.01890090039008</pub-id><pub-id pub-id-type="pmid">7646870</pub-id></element-citation></ref><ref id="B62-molecules-25-05666"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>M.J.</given-names></name></person-group><article-title>Singlet oxygen-mediated damage to proteins and its consequences</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2003</year><volume>305</volume><fpage>761</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1016/S0006-291X(03)00817-9</pub-id><pub-id pub-id-type="pmid">12763058</pub-id></element-citation></ref><ref id="B63-molecules-25-05666"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bicalho</surname><given-names>L.S.</given-names></name><name><surname>Longo</surname><given-names>J.P.F.</given-names></name><name><surname>Pereira</surname><given-names>L.O.</given-names></name><name><surname>Santos</surname><given-names>M.F.M.A.</given-names></name><name><surname>Azevedo</surname><given-names>R.B.</given-names></name></person-group><article-title>Photodynamic therapy, a new approach in the treatment of oral cancer</article-title><source>Rev. Univ. Ind. Santander. Salud.</source><year>2010</year><volume>42</volume><fpage>167</fpage><lpage>174</lpage></element-citation></ref><ref id="B64-molecules-25-05666"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>J.O.</given-names></name><name><surname>Lim</surname><given-names>Y.C.</given-names></name><name><surname>Kim</surname><given-names>Y.M.</given-names></name><name><surname>Ha</surname><given-names>K.S.</given-names></name></person-group><article-title>Differential cytotoxic responses to low-and high-dose photodynamic therapy in human gastric and bladder cancer cells</article-title><source>J. Cell Biochem.</source><year>2011</year><volume>112</volume><fpage>3061</fpage><lpage>3071</lpage><pub-id pub-id-type="doi">10.1002/jcb.23231</pub-id><pub-id pub-id-type="pmid">21678478</pub-id></element-citation></ref><ref id="B65-molecules-25-05666"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghissi</surname><given-names>K.</given-names></name><name><surname>Dixon</surname><given-names>K.</given-names></name><name><surname>Parson</surname><given-names>R.J.</given-names></name></person-group><article-title>A controlled trial of Nd-YAG laser vs photodynamic therapy for odvanced malignant bronchial obstruction</article-title><source>Laser Med. Sci.</source><year>1993</year><volume>8</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1007/BF02547850</pub-id></element-citation></ref><ref id="B66-molecules-25-05666"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Okunaka</surname><given-names>T.</given-names></name><name><surname>Shimatani</surname><given-names>H.</given-names></name></person-group><article-title>Photodynamic therapy for early state bronchogenic carcinoma</article-title><source>J. Clin. Laser Med. Surg.</source><year>1996</year><volume>14</volume><fpage>235</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1089/clm.1996.14.235</pub-id><?supplied-pmid 9612188?><pub-id pub-id-type="pmid">9612188</pub-id></element-citation></ref><ref id="B67-molecules-25-05666"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manoto</surname><given-names>S.L.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>Effect of a newly synthesized Zn sulfophthalocyanine derivative on cell morphology, viability, proliferation, and cytotoxicity in a human lung cancer cell line (A549)</article-title><source>Lasers Med. Sci.</source><year>2011</year><volume>26</volume><fpage>523</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1007/s10103-011-0887-0</pub-id><pub-id pub-id-type="pmid">21279402</pub-id></element-citation></ref><ref id="B68-molecules-25-05666"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jheon</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>J.M.</given-names></name><name><surname>Kim</surname><given-names>J.K.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Seo</surname><given-names>S.J.</given-names></name></person-group><article-title>Photodynamic therapy for tracheobronchial cancer</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2011</year><volume>6</volume><fpage>177</fpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2011.03.176</pub-id></element-citation></ref><ref id="B69-molecules-25-05666"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>W.E.</given-names></name><name><surname>MacRobert</surname><given-names>A.J.</given-names></name><name><surname>Bown</surname><given-names>S.G.</given-names></name><name><surname>Hopper</surname><given-names>C.</given-names></name><name><surname>Speight</surname><given-names>P.M.</given-names></name></person-group><article-title>Photodynamic therapy of oral cancer: Photosensitization with systemic aminolaevulinic acid</article-title><source>Lancet</source><year>1993</year><volume>342</volume><fpage>147</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/0140-6736(93)91347-O</pub-id><pub-id pub-id-type="pmid">7687318</pub-id></element-citation></ref><ref id="B70-molecules-25-05666"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>H.</given-names></name><name><surname>Shepherd</surname><given-names>N.A.</given-names></name><name><surname>Dix</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>D.J.H.</given-names></name><name><surname>Tan</surname><given-names>W.C.</given-names></name><name><surname>Krasner</surname><given-names>N.</given-names></name></person-group><article-title>Eradication of high-grade dysplasia in columnar-lined (Barrett&#x000b4;s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX</article-title><source>Lancet</source><year>1996</year><volume>348</volume><fpage>584</fpage><lpage>585</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(96)03054-1</pub-id><pub-id pub-id-type="pmid">8774572</pub-id></element-citation></ref><ref id="B71-molecules-25-05666"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J.D.</given-names></name><name><surname>Baron</surname><given-names>E.D.</given-names></name><name><surname>Scull</surname><given-names>H.</given-names></name><name><surname>Hsia</surname><given-names>A.</given-names></name><name><surname>Berlin</surname><given-names>J.C.</given-names></name><name><surname>McCormick</surname><given-names>T.</given-names></name><name><surname>Colussi</surname><given-names>V.</given-names></name><name><surname>Kenney</surname><given-names>M.E.</given-names></name><name><surname>Cooper</surname><given-names>K.D.</given-names></name><name><surname>Oleinick</surname><given-names>N.L.</given-names></name></person-group><article-title>Photodynamic therapy with the phtalocyanin photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-tranlational studies</article-title><source>Toxicol. Appl. Pharmacol.</source><year>2007</year><volume>224</volume><fpage>290</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2007.01.025</pub-id><pub-id pub-id-type="pmid">17397888</pub-id></element-citation></ref><ref id="B72-molecules-25-05666"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nseyo</surname><given-names>U.O.</given-names></name><name><surname>DeHaven</surname><given-names>J.</given-names></name><name><surname>Dougherty</surname><given-names>T.J.</given-names></name><name><surname>Potter</surname><given-names>W.R.</given-names></name><name><surname>Merrill</surname><given-names>D.L.</given-names></name><name><surname>Lundahl</surname><given-names>S.L.</given-names></name><name><surname>Lamm</surname><given-names>D.L.</given-names></name></person-group><article-title>Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: A long-term experience</article-title><source>J. Clin. Laser Med. Surg.</source><year>1998</year><volume>16</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1089/clm.1998.16.61</pub-id><pub-id pub-id-type="pmid">9728133</pub-id></element-citation></ref><ref id="B73-molecules-25-05666"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leon</surname><given-names>S.P.</given-names></name><name><surname>Folkerth</surname><given-names>R.D.</given-names></name><name><surname>Black</surname><given-names>P.</given-names></name></person-group><article-title>Microvessel density is a prognostic indicator for patients with astroglial brain tumors</article-title><source>Cancer</source><year>1996</year><volume>77</volume><fpage>362</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19960115)77:2&#x0003c;362::AID-CNCR20&#x0003e;3.0.CO;2-Z</pub-id><pub-id pub-id-type="pmid">8625246</pub-id></element-citation></ref><ref id="B74-molecules-25-05666"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>T.C.</given-names></name><name><surname>Finlay</surname><given-names>J.C.</given-names></name></person-group><article-title>The role of photodynamic therapy (PDT) physics</article-title><source>Med. Phys.</source><year>2008</year><volume>35</volume><fpage>3127</fpage><lpage>3136</lpage><pub-id pub-id-type="doi">10.1118/1.2937440</pub-id><?supplied-pmid 18697538?><pub-id pub-id-type="pmid">18697538</pub-id></element-citation></ref><ref id="B75-molecules-25-05666"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>George</surname><given-names>B.P.A.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>A review on novel breast cancer therapies: Photodynamic therapy and plant derived agent induced cell death mechanisms</article-title><source>Anticancer Agents Med. Chem.</source><year>2016</year><volume>16</volume><fpage>793</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.2174/1871520615666151026094028</pub-id><?supplied-pmid 26499768?><pub-id pub-id-type="pmid">26499768</pub-id></element-citation></ref><ref id="B76-molecules-25-05666"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostovi&#x00107;</surname><given-names>K.</given-names></name><name><surname>Pastar</surname><given-names>Z.</given-names></name><name><surname>Ceovi&#x00107;</surname><given-names>R.</given-names></name><name><surname>Mokos</surname><given-names>Z.B.</given-names></name><name><surname>Buzina</surname><given-names>D.S.</given-names></name><name><surname>Stanimirovi&#x00107;</surname><given-names>A.</given-names></name></person-group><article-title>Photodynamic therapy in dermatology: Current treatments and implications</article-title><source>Coll. Antropol.</source><year>2012</year><volume>36</volume><fpage>1477</fpage><lpage>1481</lpage><?supplied-pmid 23390855?><pub-id pub-id-type="pmid">23390855</pub-id></element-citation></ref><ref id="B77-molecules-25-05666"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessel</surname><given-names>D.</given-names></name></person-group><article-title>Photosensitization of viral particles</article-title><source>J. Lab. Clin. Med.</source><year>1990</year><volume>116</volume><fpage>428</fpage><?supplied-pmid 2212852?><pub-id pub-id-type="pmid">2212852</pub-id></element-citation></ref><ref id="B78-molecules-25-05666"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tardivo</surname><given-names>J.P.</given-names></name><name><surname>Del Giglio</surname><given-names>A.</given-names></name><name><surname>Paschoal</surname><given-names>L.H.</given-names></name><name><surname>Baptista</surname><given-names>M.S.</given-names></name></person-group><article-title>New photodynamic therapy protocol to treat AIDS-related Kaposi&#x000b4;s sarcoma</article-title><source>Photomed. Laser Surg.</source><year>2006</year><volume>24</volume><fpage>528</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1089/pho.2006.24.528</pub-id><?supplied-pmid 16942436?><pub-id pub-id-type="pmid">16942436</pub-id></element-citation></ref><ref id="B79-molecules-25-05666"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x0013a;kvy</surname><given-names>P.</given-names></name></person-group><article-title>Position and possibilities of photodynamic therapy in oncology</article-title><source>Oncology</source><year>2007</year><volume>5</volume><fpage>299</fpage><lpage>301</lpage></element-citation></ref><ref id="B80-molecules-25-05666"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castano</surname><given-names>A.P.</given-names></name><name><surname>Demidova</surname><given-names>T.N.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name></person-group><article-title>Mechanisms in photodynamic therapy: Part three&#x02014;Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2005</year><volume>2</volume><fpage>91</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/S1572-1000(05)00060-8</pub-id><pub-id pub-id-type="pmid">25048669</pub-id></element-citation></ref><ref id="B81-molecules-25-05666"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muniyandi</surname><given-names>K.</given-names></name><name><surname>George</surname><given-names>B.</given-names></name><name><surname>Parimelazhagan</surname><given-names>T.</given-names></name><name><surname>Abrahamse</surname><given-names>H.</given-names></name></person-group><article-title>Role of photoactive phytocompounds in photodynamic therapy of cancer</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>4102</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25184102</pub-id></element-citation></ref><ref id="B82-molecules-25-05666"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>R.E.</given-names></name><name><surname>Sazanovich</surname><given-names>I.V.</given-names></name><name><surname>McKenzie</surname><given-names>L.K.</given-names></name><name><surname>Stasheuski</surname><given-names>A.S.</given-names></name><name><surname>Coyle</surname><given-names>R.</given-names></name><name><surname>Baggaley</surname><given-names>E.</given-names></name><name><surname>Bottomley</surname><given-names>S.</given-names></name><name><surname>Weinstein</surname><given-names>J.A.</given-names></name><name><surname>Bryant</surname><given-names>H.E.</given-names></name></person-group><article-title>Photodynamic killing of cancer cells by a platinum(II) complex with cyclometallating ligand</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>22668</fpage><pub-id pub-id-type="doi">10.1038/srep22668</pub-id><pub-id pub-id-type="pmid">26940077</pub-id></element-citation></ref><ref id="B83-molecules-25-05666"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pouton</surname><given-names>C.W.</given-names></name><name><surname>Wagstaff</surname><given-names>K.M.</given-names></name><name><surname>Roth</surname><given-names>D.M.</given-names></name><name><surname>Moseley</surname><given-names>G.W.</given-names></name><name><surname>Jans</surname><given-names>D.A.</given-names></name></person-group><article-title>Targeted delivery to the nucleus</article-title><source>Adv. Drug Deliv. Rev.</source><year>2007</year><volume>59</volume><fpage>698</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2007.06.010</pub-id><?supplied-pmid 17681634?><pub-id pub-id-type="pmid">17681634</pub-id></element-citation></ref><ref id="B84-molecules-25-05666"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobolev</surname><given-names>A.S.</given-names></name></person-group><article-title>Novel modular transporters delivering anticancer drugs and foreign DNA to the nuclei of target cancer cells</article-title><source>J. Buon.</source><year>2009</year><volume>14</volume><issue>Suppl. 1</issue><fpage>S33</fpage><lpage>S42</lpage><pub-id pub-id-type="pmid">19785068</pub-id></element-citation></ref><ref id="B85-molecules-25-05666"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Melo</surname><given-names>W.C.M.A.</given-names></name><name><surname>Lee</surname><given-names>A.N.</given-names></name><name><surname>Perussi</surname><given-names>J.R.</given-names></name><name><surname>Hamblin</surname><given-names>M.R.</given-names></name></person-group><article-title>Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin</article-title><source>Photodiagnosis Photodyn. Ther.</source><year>2013</year><volume>10</volume><fpage>647</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2013.08.001</pub-id><?supplied-pmid 24284122?><pub-id pub-id-type="pmid">24284122</pub-id></element-citation></ref><ref id="B86-molecules-25-05666"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>D.S.</given-names></name><name><surname>P&#x000e9;rez-Fons</surname><given-names>L.</given-names></name><name><surname>Estepa</surname><given-names>A.</given-names></name><name><surname>Micol</surname><given-names>V.</given-names></name></person-group><article-title>Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin</article-title><source>Biochem. Pharmacol.</source><year>2004</year><volume>68</volume><fpage>549</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2004.04.012</pub-id><pub-id pub-id-type="pmid">15242821</pub-id></element-citation></ref><ref id="B87-molecules-25-05666"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>K.</given-names></name><name><surname>Xia</surname><given-names>Q.</given-names></name><name><surname>Heng</surname><given-names>H.</given-names></name><name><surname>Feng</surname><given-names>F.</given-names></name></person-group><article-title>Temozolomide-doxorubicin conjugate as a double intercalating agent and delivery by apoferritin for glioblastoma chemotherapy</article-title><source>ACS Mater. Interfaces</source><year>2020</year><volume>12</volume><fpage>34599</fpage><lpage>34609</lpage><pub-id pub-id-type="doi">10.1021/acsami.0c08531</pub-id><?supplied-pmid 32648735?><pub-id pub-id-type="pmid">32648735</pub-id></element-citation></ref><ref id="B88-molecules-25-05666"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelli</surname><given-names>F.</given-names></name><name><surname>Vignetti</surname><given-names>M.</given-names></name><name><surname>Suciu</surname><given-names>S.</given-names></name><name><surname>Stasi</surname><given-names>R.</given-names></name><name><surname>Petti</surname><given-names>M.C.</given-names></name><name><surname>Meloni</surname><given-names>G.</given-names></name><name><surname>Muus</surname><given-names>P.</given-names></name><name><surname>Marmont</surname><given-names>F.</given-names></name><name><surname>Marie</surname><given-names>J.P.</given-names></name><name><surname>Labar</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: The EORTC and GIMEMA groups study AML-10</article-title><source>J. Clin. Oncol.</source><year>2009</year><volume>27</volume><fpage>5397</fpage><lpage>5403</lpage><pub-id pub-id-type="doi">10.1200/JCO.2008.20.6490</pub-id><?supplied-pmid 19826132?><pub-id pub-id-type="pmid">19826132</pub-id></element-citation></ref><ref id="B89-molecules-25-05666"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x000f3;jcik</surname><given-names>K.</given-names></name><name><surname>Zarebski</surname><given-names>M.</given-names></name><name><surname>Cossarizza</surname><given-names>A.</given-names></name><name><surname>Dobrucki</surname><given-names>J.W.</given-names></name></person-group><article-title>Daunomycin, an antitumor DNA intercalator, influences histone-DNA interactions</article-title><source>Cancer Biol. Ther.</source><year>2013</year><volume>14</volume><fpage>823</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.4161/cbt.25328</pub-id><?supplied-pmid 23792590?><pub-id pub-id-type="pmid">23792590</pub-id></element-citation></ref><ref id="B90-molecules-25-05666"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name></person-group><article-title>Design and synthesis of various quinizarin derivatives as potential anticancer agents in acute T lymphoblastic leukemia</article-title><source>Bioorganic Med. Chem.</source><year>2019</year><volume>27</volume><fpage>1362</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2019.02.041</pub-id><?supplied-pmid 30827866?><pub-id pub-id-type="pmid">30827866</pub-id></element-citation></ref><ref id="B91-molecules-25-05666"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>He</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Qin</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name></person-group><article-title>Danthron suppresses autophagy and sensitizers pancreatic cancer cells to doxorubicin</article-title><source>Toxicol. In Vitro</source><year>2019</year><volume>54</volume><fpage>345</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2018.10.019</pub-id><pub-id pub-id-type="pmid">30389604</pub-id></element-citation></ref><ref id="B92-molecules-25-05666"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Qian</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>G.</given-names></name><name><surname>Ji</surname><given-names>L.</given-names></name><name><surname>Suo</surname><given-names>A.</given-names></name></person-group><article-title>Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer</article-title><source>Carbohydr. Polym.</source><year>2019</year><volume>203</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2018.09.035</pub-id><pub-id pub-id-type="pmid">30318205</pub-id></element-citation></ref><ref id="B93-molecules-25-05666"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Shin</surname><given-names>H.</given-names></name><name><surname>Han</surname><given-names>H.</given-names></name><name><surname>Na</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name></person-group><article-title>Combination of chemotherapy and photodynamic therapy for cancer treatment with sonoporation effects</article-title><source>J. Control. Release</source><year>2018</year><volume>283</volume><fpage>190</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2018.06.008</pub-id><?supplied-pmid 29885415?><pub-id pub-id-type="pmid">29885415</pub-id></element-citation></ref><ref id="B94-molecules-25-05666"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name></person-group><article-title>self-assembled core-shell nanoparticles for combined chemotherapy and photodynamic therapy of resistant head and neck cancers</article-title><source>ACS Nano</source><year>2015</year><volume>9</volume><fpage>991</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1021/nn506963h</pub-id><?supplied-pmid 25559017?><pub-id pub-id-type="pmid">25559017</pub-id></element-citation></ref><ref id="B95-molecules-25-05666"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gleason</surname><given-names>H.A.</given-names></name><name><surname>Cronquist</surname><given-names>A.</given-names></name></person-group><source>Manual of Vascular Plants of Northeastern United States and Adjacent Canada</source><edition>2nd ed.</edition><publisher-name>New York Botanical Garden</publisher-name><publisher-loc>Bronx, New York, NY, USA</publisher-loc><year>1991</year><fpage>910</fpage></element-citation></ref><ref id="B96-molecules-25-05666"><label>96.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>A.</given-names></name></person-group><article-title>Bioactive natural products (Part C)</article-title><source>Studies in Natural Products Chemistry</source><edition>1st ed.</edition><person-group person-group-type="editor"><name><surname>Rahman</surname><given-names>A.</given-names></name></person-group><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2000</year><volume>Volume 22</volume><fpage>647</fpage></element-citation></ref><ref id="B97-molecules-25-05666"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name></person-group><article-title>Hypericin&#x02014;A new antiviral and antitumor photosensitizer: Mechanism of action and interaction with biological macromolecules</article-title><source>Curr. Drug Targets</source><year>2002</year><volume>3</volume><fpage>55</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.2174/1389450023348091</pub-id><?supplied-pmid 11899265?><pub-id pub-id-type="pmid">11899265</pub-id></element-citation></ref><ref id="B98-molecules-25-05666"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornett</surname><given-names>A.</given-names></name></person-group><article-title>Use of hypericin as antidepressant. Valid measure of antidepressant efficacy in primary care is needed</article-title><source>Brit. Med. J.</source><year>2000</year><volume>320</volume><fpage>1141</fpage></element-citation></ref><ref id="B99-molecules-25-05666"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterweck</surname><given-names>V.</given-names></name><name><surname>Winterhoff</surname><given-names>H.</given-names></name><name><surname>Herkenham</surname><given-names>M.</given-names></name></person-group><article-title>St John&#x000b4;s wort, hypericin, and imipramine: A comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats</article-title><source>Mol. Psychiatry</source><year>2001</year><volume>6</volume><fpage>547</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1038/sj.mp.4000937</pub-id><pub-id pub-id-type="pmid">11526469</pub-id></element-citation></ref><ref id="B100-molecules-25-05666"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberman</surname><given-names>R.</given-names></name><name><surname>Alth</surname><given-names>G.</given-names></name><name><surname>Kreitner</surname><given-names>M.</given-names></name><name><surname>Kubin</surname><given-names>A.</given-names></name></person-group><article-title>Natural products derived from plants as potential drugs for the photodynamic destruction of tumor cells</article-title><source>J. Photochem. Photobiol. B</source><year>1996</year><volume>36</volume><fpage>95</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/S1011-1344(96)07353-8</pub-id><pub-id pub-id-type="pmid">9002245</pub-id></element-citation></ref><ref id="B101-molecules-25-05666"><label>101.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pengelly</surname><given-names>A.</given-names></name></person-group><source>The Constituents of Medical Plants: An Introduction to the Chemistry and Therapeutics of Herbal Medicine</source><edition>2nd ed.</edition><publisher-name>CABI Publishing</publisher-name><publisher-loc>Cambridge, UK</publisher-loc><year>2004</year><fpage>20</fpage><lpage>50</lpage></element-citation></ref><ref id="B102-molecules-25-05666"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miro&#x00161;&#x00161;ay</surname><given-names>A.</given-names></name><name><surname>Mirossay</surname><given-names>L.</given-names></name><name><surname>T&#x000f3;thov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Onderkov&#x000e1;</surname><given-names>H.</given-names></name><name><surname>Moj&#x0017e;i&#x00161;</surname><given-names>J.</given-names></name></person-group><article-title>Potentiation of hypericin and hypocrellin-induced phototoxicity by omeprazole</article-title><source>Phytomedicine</source><year>1999</year><volume>6</volume><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(99)80051-8</pub-id><pub-id pub-id-type="pmid">11962536</pub-id></element-citation></ref><ref id="B103-molecules-25-05666"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavarga</surname><given-names>I.</given-names></name><name><surname>Brezani</surname><given-names>P.</given-names></name><name><surname>Fedorocko</surname><given-names>P.</given-names></name><name><surname>Miskovsky</surname><given-names>P.</given-names></name><name><surname>Bobrov</surname><given-names>N.</given-names></name><name><surname>Longauer</surname><given-names>F.</given-names></name><name><surname>Rybarova</surname><given-names>S.</given-names></name><name><surname>Mirossay</surname><given-names>L.</given-names></name><name><surname>Stubna</surname><given-names>J.</given-names></name></person-group><article-title>Photoinduced antitumor effect of hypericin can be enhanced by fractionated dosing</article-title><source>Photomedicine</source><year>2005</year><volume>12</volume><fpage>680</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2004.02.011</pub-id></element-citation></ref><ref id="B104-molecules-25-05666"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plenagl</surname><given-names>N.</given-names></name><name><surname>Duse</surname><given-names>L.</given-names></name><name><surname>Seitz</surname><given-names>B.S.</given-names></name><name><surname>Goergen</surname><given-names>N.</given-names></name><name><surname>Pinnapireddy</surname><given-names>S.R.</given-names></name><name><surname>Jedelska</surname><given-names>J.</given-names></name><name><surname>Br&#x00171;&#x003b2;ler</surname><given-names>J.</given-names></name><name><surname>Bakowsky</surname><given-names>U.</given-names></name></person-group><article-title>Photodynamic therapy&#x02014;hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity</article-title><source>J. Drug Deliv.</source><year>2019</year><volume>26</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1080/10717544.2018.1531954</pub-id></element-citation></ref><ref id="B105-molecules-25-05666"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchini</surname><given-names>P.</given-names></name><name><surname>Cozzolino</surname><given-names>M.</given-names></name><name><surname>Oneto</surname><given-names>M.</given-names></name><name><surname>Pesce</surname><given-names>L.</given-names></name><name><surname>Pennacchietti</surname><given-names>F.</given-names></name><name><surname>Tognolini</surname><given-names>M.</given-names></name><name><surname>Giorgio</surname><given-names>C.</given-names></name><name><surname>Nonell</surname><given-names>S.</given-names></name><name><surname>Cavanna</surname><given-names>L.</given-names></name><name><surname>Delcanale</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Hypericin-apomyoglobin an enhanced photosensitizer complex for the treatment of tumor cells</article-title><source>Biomacromolecules</source><year>2019</year><volume>20</volume><fpage>2024</fpage><lpage>2033</lpage><pub-id pub-id-type="doi">10.1021/acs.biomac.9b00222</pub-id><pub-id pub-id-type="pmid">30995399</pub-id></element-citation></ref><ref id="B106-molecules-25-05666"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiebich</surname><given-names>B.L.</given-names></name><name><surname>Lieb</surname><given-names>A.H.</given-names></name></person-group><article-title>Inhibition of substance P induced cytokine synthesis by St John&#x000b4;s Wort extracts</article-title><source>Pharmacopsychiatry</source><year>2001</year><volume>34</volume><fpage>526</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1055/s-2001-15462</pub-id><?supplied-pmid 11518071?><pub-id pub-id-type="pmid">11518071</pub-id></element-citation></ref><ref id="B107-molecules-25-05666"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samadi</surname><given-names>S.</given-names></name><name><surname>Khadivzadeh</surname><given-names>T.</given-names></name><name><surname>Emami</surname><given-names>A.</given-names></name><name><surname>Moosavi</surname><given-names>N.S.</given-names></name><name><surname>Tafaghodi</surname><given-names>M.</given-names></name><name><surname>Behnam</surname><given-names>H.R.</given-names></name></person-group><article-title>The effect of Hypericum perforatum on the wound healing and scar of cesarean</article-title><source>J. Altern. Complement. Med.</source><year>2010</year><volume>16</volume><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1089/acm.2009.0317</pub-id><pub-id pub-id-type="pmid">20064022</pub-id></element-citation></ref><ref id="B108-molecules-25-05666"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajhashemi</surname><given-names>M.</given-names></name><name><surname>Ghanbari</surname><given-names>Z.</given-names></name><name><surname>Movahedi</surname><given-names>M.</given-names></name><name><surname>Rafieian</surname><given-names>M.</given-names></name><name><surname>Keivani</surname><given-names>A.</given-names></name><name><surname>Haghollahi</surname><given-names>F.</given-names></name></person-group><article-title>The effect of Achillea millefolium and Hypericum perforatum ointments on episiotomy wound healing in primiparous women</article-title><source>J. Matern. Fetal Neonatal Med.</source><year>2018</year><volume>31</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1080/14767058.2016.1275549</pub-id><?supplied-pmid 28027682?><pub-id pub-id-type="pmid">28027682</pub-id></element-citation></ref><ref id="B109-molecules-25-05666"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>I.</given-names></name><name><surname>Ballesta</surname><given-names>S.</given-names></name><name><surname>Gilaberte</surname><given-names>Y.</given-names></name><name><surname>Rezusta</surname><given-names>A.</given-names></name><name><surname>Pascual</surname><given-names>&#x000c1;.</given-names></name></person-group><article-title>Antimicrobial photodynamic activity of hypericin against methicillin-susceptible and resistant Staphylococcus aureus biofilms</article-title><source>Future Microbiol.</source><year>2015</year><volume>10</volume><fpage>347</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.2217/fmb.14.114</pub-id><?supplied-pmid 25812458?><pub-id pub-id-type="pmid">25812458</pub-id></element-citation></ref><ref id="B110-molecules-25-05666"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelhardt</surname><given-names>V.</given-names></name><name><surname>Krammer</surname><given-names>B.</given-names></name><name><surname>Plaetzer</surname><given-names>K.</given-names></name></person-group><article-title>Antibacterial photodynamic therapy using water-soluble formulations of hypericin or mTHPC is effective in inactivation of Staphylococcus aureus</article-title><source>Photochem. Photobiol. Sci.</source><year>2010</year><volume>9</volume><fpage>365</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1039/b9pp00144a</pub-id><?supplied-pmid 20221463?><pub-id pub-id-type="pmid">20221463</pub-id></element-citation></ref><ref id="B111-molecules-25-05666"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yow</surname><given-names>C.</given-names></name><name><surname>Tang</surname><given-names>H.M.</given-names></name><name><surname>Chu</surname><given-names>E.S.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name></person-group><article-title>Hypericin-mediated photodynamic antimicrobial effect on clinically isolated pathogens</article-title><source>Photochem. Photobiol.</source><year>2012</year><volume>88</volume><fpage>626</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.2012.01085.x</pub-id><pub-id pub-id-type="pmid">22233203</pub-id></element-citation></ref><ref id="B112-molecules-25-05666"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-Amigo</surname><given-names>B.</given-names></name><name><surname>Delcanale</surname><given-names>P.</given-names></name><name><surname>Rotger</surname><given-names>G.</given-names></name><name><surname>Ju&#x000e1;rez-Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>Abbruzzetti</surname><given-names>S.</given-names></name><name><surname>Summer</surname><given-names>A.</given-names></name><name><surname>Agut</surname><given-names>M.</given-names></name><name><surname>Luque</surname><given-names>F.J.</given-names></name><name><surname>Nonell</surname><given-names>S.</given-names></name><name><surname>Viappiani</surname><given-names>C.</given-names></name></person-group><article-title>The complex of hypericin with &#x003b2;-lactoglobulin has antimicrobial activity with perspective applications in dairy industry</article-title><source>J. Dairy Sci.</source><year>2015</year><volume>98</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.3168/jds.2014-8691</pub-id><pub-id pub-id-type="pmid">25465550</pub-id></element-citation></ref><ref id="B113-molecules-25-05666"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delcanale</surname><given-names>P.</given-names></name><name><surname>Rodr&#x000ed;guez-Amigo</surname><given-names>B.</given-names></name><name><surname>Ju&#x000e1;rez-Jim&#x000e9;nez</surname><given-names>J.</given-names></name><name><surname>Luque</surname><given-names>F.J.</given-names></name><name><surname>Abbruzzetti</surname><given-names>S.</given-names></name><name><surname>Agut</surname><given-names>M.</given-names></name><name><surname>Nonell</surname><given-names>S.</given-names></name><name><surname>Viappiani</surname><given-names>C.</given-names></name></person-group><article-title>Tuning the local solvent composition at a drug carrier surface: Effect of dimethyl sulfoxide/water mixture on the photofunctional properties of hyperici-&#x003b2;-lactoglobulin</article-title><source>Mat. Chem. B</source><year>2017</year><volume>5</volume><fpage>1633</fpage><lpage>1641</lpage><pub-id pub-id-type="doi">10.1039/C7TB00081B</pub-id></element-citation></ref><ref id="B114-molecules-25-05666"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezzuoli</surname><given-names>D.</given-names></name><name><surname>Cozzolino</surname><given-names>M.</given-names></name><name><surname>Montali</surname><given-names>C.</given-names></name><name><surname>Brancaleon</surname><given-names>L.</given-names></name><name><surname>Bianchini</surname><given-names>P.</given-names></name><name><surname>Zantedeschi</surname><given-names>M.</given-names></name><name><surname>Bonardi</surname><given-names>S.</given-names></name><name><surname>Viappiani</surname><given-names>C.</given-names></name><name><surname>Abbruzzetti</surname><given-names>S.</given-names></name></person-group><article-title>Serum albumins are efficient delivery systems for the photosensitizer hypericin in photosensitization-based treatments against Staphylococcus aureus</article-title><source>Food Control.</source><year>2018</year><volume>94</volume><fpage>254</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2018.07.027</pub-id></element-citation></ref><ref id="B115-molecules-25-05666"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Bazzocchi</surname><given-names>I.</given-names></name><name><surname>Hudson</surname><given-names>J.B.</given-names></name><name><surname>Towers</surname><given-names>G.H.</given-names></name></person-group><article-title>Antiviral activity of photoactive plant pigment hypericin</article-title><source>Photochem. Photobiol.</source><year>1991</year><volume>54</volume><fpage>95</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1991.tb01990.x</pub-id><pub-id pub-id-type="pmid">1658826</pub-id></element-citation></ref><ref id="B116-molecules-25-05666"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>J.B.</given-names></name><name><surname>Lopez-Bazzocchi</surname><given-names>I.</given-names></name><name><surname>Towers</surname><given-names>G.H.</given-names></name></person-group><article-title>Antiviral activities of hypericin</article-title><source>Antivir. Res.</source><year>1991</year><volume>15</volume><fpage>101</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(91)90028-P</pub-id><pub-id pub-id-type="pmid">1650164</pub-id></element-citation></ref><ref id="B117-molecules-25-05666"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moraleda</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>T.T.</given-names></name><name><surname>Jilbert</surname><given-names>A.R.</given-names></name><name><surname>Aldrich</surname><given-names>C.E.</given-names></name><name><surname>Condreay</surname><given-names>L.D.</given-names></name><name><surname>Larsen</surname><given-names>S.H.</given-names></name><name><surname>Tang</surname><given-names>J.C.</given-names></name><name><surname>Colacino</surname><given-names>J.M.</given-names></name><name><surname>Mason</surname><given-names>W.S.</given-names></name></person-group><article-title>Inhibition of duck hepatitis B virus replication by hypericin</article-title><source>Antivir. Res.</source><year>1993</year><volume>20</volume><fpage>235</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(93)90023-C</pub-id><pub-id pub-id-type="pmid">8470884</pub-id></element-citation></ref><ref id="B118-molecules-25-05666"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guedes</surname><given-names>R.C.</given-names></name><name><surname>Eriksson</surname><given-names>L.A.</given-names></name></person-group><article-title>Effects of halogen substitution on the photochemical properties of hypericin</article-title><source>J. Photochem. Photobiol. A Chem.</source><year>2006</year><volume>178</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.jphotochem.2005.06.018</pub-id></element-citation></ref><ref id="B119-molecules-25-05666"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meruelo</surname><given-names>D.</given-names></name><name><surname>Lavie</surname><given-names>G.</given-names></name><name><surname>Lavie</surname><given-names>D.</given-names></name></person-group><article-title>Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: Aromatic polycyclic diones hypericin and pseudohypericin</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1988</year><volume>85</volume><fpage>5230</fpage><lpage>5234</lpage><pub-id pub-id-type="doi">10.1073/pnas.85.14.5230</pub-id><pub-id pub-id-type="pmid">2839837</pub-id></element-citation></ref><ref id="B120-molecules-25-05666"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>J.B.</given-names></name><name><surname>Imperial</surname><given-names>V.</given-names></name><name><surname>Haugland</surname><given-names>R.P.</given-names></name><name><surname>Diwu</surname><given-names>Z.</given-names></name></person-group><article-title>Antiviral activities of photoactive perylenequinones</article-title><source>Photochem. Photobiol.</source><year>1997</year><volume>65</volume><fpage>352</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1997.tb08570.x</pub-id><pub-id pub-id-type="pmid">9066311</pub-id></element-citation></ref><ref id="B121-molecules-25-05666"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>C.</given-names></name></person-group><article-title>Raman spectroscopy study on structure of human immunodeficiency virus (HIV) and hypericin-induced photosensitive damage of HIV</article-title><source>Sci. China Ser. C</source><year>2005</year><volume>48</volume><fpage>117</fpage><lpage>132</lpage></element-citation></ref><ref id="B122-molecules-25-05666"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulick</surname><given-names>R.M.</given-names></name><name><surname>McAuliffe</surname><given-names>V.</given-names></name><name><surname>Holden-Wiltse</surname><given-names>J.</given-names></name><name><surname>Crumpacker</surname><given-names>C.</given-names></name><name><surname>Liebes</surname><given-names>L.</given-names></name><name><surname>Stein</surname><given-names>D.S.</given-names></name><name><surname>Meehan</surname><given-names>P.</given-names></name><name><surname>Hussey</surname><given-names>S.</given-names></name><name><surname>Forcht</surname><given-names>J.</given-names></name><name><surname>Valentine</surname><given-names>F.T.</given-names></name></person-group><article-title>Phase I studies of hypericin, the active compound in St. John&#x000b4;s Wort, as an antiretroviral agent in HIV-infected adults: AIDS clinical trials group protocols 150 and 258</article-title><source>Ann. Intern. Med.</source><year>1999</year><volume>130</volume><fpage>510</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-130-6-199903160-00015</pub-id><pub-id pub-id-type="pmid">10075619</pub-id></element-citation></ref><ref id="B123-molecules-25-05666"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerb</surname><given-names>R.</given-names></name><name><surname>Reum</surname><given-names>T.</given-names></name><name><surname>Brockm&#x000f6;ller</surname><given-names>J.</given-names></name><name><surname>Bauer</surname><given-names>S.</given-names></name><name><surname>Roots</surname><given-names>I.</given-names></name></person-group><article-title>No clinically relevant photosensitization after single-dose and steady state in treatment with hypericum extract in man</article-title><source>Eur. J. Clin. Pharmacol.</source><year>1995</year><volume>49</volume><fpage>A156</fpage></element-citation></ref><ref id="B124-molecules-25-05666"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diwu</surname><given-names>Z.</given-names></name></person-group><article-title>Novel therapeutic and diagnostic applications of hypocrellins and hypericins</article-title><source>Photochem. Photobiol.</source><year>1995</year><volume>61</volume><fpage>529</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1995.tb09903.x</pub-id><pub-id pub-id-type="pmid">7568399</pub-id></element-citation></ref><ref id="B125-molecules-25-05666"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>J.L.</given-names></name><name><surname>Cotton</surname><given-names>T.M.</given-names></name></person-group><article-title>Spectroscopic properties of hypericin in solution and at surfaces</article-title><source>J. Phys. Chem.</source><year>1995</year><volume>99</volume><fpage>4317</fpage><lpage>4323</lpage><pub-id pub-id-type="doi">10.1021/j100012a063</pub-id></element-citation></ref><ref id="B126-molecules-25-05666"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>T.</given-names></name><name><surname>Ohta</surname><given-names>N.</given-names></name><name><surname>Yamazaki</surname><given-names>I.</given-names></name><name><surname>Song</surname><given-names>P.S.</given-names></name></person-group><article-title>Excited-state properties of hypericin: Electronic spectra and fluorescence decay kinetics</article-title><source>J. Phys. Chem.</source><year>1993</year><volume>97</volume><fpage>7870</fpage><lpage>7875</lpage><pub-id pub-id-type="doi">10.1021/j100132a013</pub-id></element-citation></ref><ref id="B127-molecules-25-05666"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke&#x00161;a</surname><given-names>P.</given-names></name><name><surname>Antal&#x000ed;k</surname><given-names>M.</given-names></name></person-group><article-title>Determination of pKa constants of hypericin in aqueous solution of the anti-allergic hydrotropic drug Cromolyn disodium salt</article-title><source>Chem. Phys. Lett.</source><year>2017</year><volume>676</volume><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.cplett.2017.03.059</pub-id></element-citation></ref><ref id="B128-molecules-25-05666"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redepenning</surname><given-names>J.</given-names></name><name><surname>Tao</surname><given-names>N.</given-names></name></person-group><article-title>Measurement of formal potentials for hypericin in dimethylsulfoxide</article-title><source>Photobiol.</source><year>1993</year><volume>58</volume><fpage>532</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1993.tb04927.x</pub-id><?supplied-pmid 8248327?><pub-id pub-id-type="pmid">8248327</pub-id></element-citation></ref><ref id="B129-molecules-25-05666"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C.</given-names></name><name><surname>Pardini</surname><given-names>R.S.</given-names></name></person-group><article-title>Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells</article-title><source>Photochem. Photobiol.</source><year>1992</year><volume>55</volume><fpage>831</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1992.tb08531.x</pub-id><pub-id pub-id-type="pmid">1409890</pub-id></element-citation></ref><ref id="B130-molecules-25-05666"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrenberg</surname><given-names>B.</given-names></name><name><surname>Anderson</surname><given-names>J.L.</given-names></name><name><surname>Foote</surname><given-names>C.S.</given-names></name></person-group><article-title>Kinetics and yield of singlet oxygen photosensitized by hypericin inorganic and biological media</article-title><source>Photochem. Photobiol.</source><year>1998</year><volume>68</volume><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1998.tb02479.x</pub-id><pub-id pub-id-type="pmid">9723207</pub-id></element-citation></ref><ref id="B131-molecules-25-05666"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roslaniec</surname><given-names>M.</given-names></name><name><surname>Weitman</surname><given-names>H.</given-names></name><name><surname>Freeman</surname><given-names>D.</given-names></name><name><surname>Mazur</surname><given-names>Y.</given-names></name><name><surname>Ehrenberg</surname><given-names>B.</given-names></name></person-group><article-title>Liposome binding constant and singlet oxygen quantum yields of hypericin, tetrahydroxyhelianthrone and their derivatives: Studies in organic solutions and in liposomes</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2000</year><volume>57</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/S1011-1344(00)00090-7</pub-id></element-citation></ref><ref id="B132-molecules-25-05666"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gbur</surname><given-names>P.</given-names></name><name><surname>Dedi&#x0010d;</surname><given-names>R.</given-names></name><name><surname>Jancura</surname><given-names>D.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Hala</surname><given-names>J.</given-names></name></person-group><article-title>Time-resolved luminescence and singlet oxygen formation under illumination of hypericin in acetone</article-title><source>J. Lumin.</source><year>2008</year><volume>128</volume><fpage>765</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1016/j.jlumin.2007.11.073</pub-id></element-citation></ref><ref id="B133-molecules-25-05666"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>M.J.</given-names></name><name><surname>Carpenter</surname><given-names>S.L.</given-names></name><name><surname>Petrich</surname><given-names>J.W.</given-names></name></person-group><article-title>The role of oxygen in the photoinduced antiviral activity of hypericin</article-title><source>Bioorg. Med. Chem. Lett.</source><year>1994</year><volume>4</volume><fpage>1339</fpage><lpage>1344</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(01)80357-7</pub-id></element-citation></ref><ref id="B134-molecules-25-05666"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>S.</given-names></name><name><surname>Fehr</surname><given-names>J.M.</given-names></name><name><surname>Kraus</surname><given-names>G.A.</given-names></name><name><surname>Petrich</surname><given-names>J.W.</given-names></name></person-group><article-title>Chemiluminescent activation of the antiviral activity of hypericin: A molecular flashlight</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>12273</fpage><lpage>12277</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.25.12273</pub-id><?supplied-pmid 7991618?><pub-id pub-id-type="pmid">7991618</pub-id></element-citation></ref><ref id="B135-molecules-25-05666"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verebov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Belej</surname><given-names>D.</given-names></name><name><surname>Joniov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Jura&#x00161;ekov&#x000e1;</surname><given-names>Z.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Ko&#x0017e;&#x000e1;r</surname><given-names>T.</given-names></name><name><surname>Horv&#x000e1;th</surname><given-names>D.</given-names></name><name><surname>Stani&#x0010d;ov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Hunto&#x00161;ov&#x000e1;</surname><given-names>V.</given-names></name></person-group><article-title>Deeper insights into the drug defense of glioma cells against hydrophobic molecules</article-title><source>Int. J. Pharm.</source><year>2016</year><volume>503</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2016.02.042</pub-id><pub-id pub-id-type="pmid">26940808</pub-id></element-citation></ref><ref id="B136-molecules-25-05666"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Witte</surname><given-names>P.</given-names></name><name><surname>Agostinis</surname><given-names>P.</given-names></name><name><surname>Van Lint</surname><given-names>J.</given-names></name><name><surname>Merlevede</surname><given-names>W.</given-names></name><name><surname>Vandenheede</surname><given-names>J.R.</given-names></name></person-group><article-title>Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin</article-title><source>Biochem. Pharmacol.</source><year>1993</year><volume>46</volume><fpage>1929</fpage><lpage>1936</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(93)90633-8</pub-id><pub-id pub-id-type="pmid">8267642</pub-id></element-citation></ref><ref id="B137-molecules-25-05666"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agostinis</surname><given-names>P.</given-names></name><name><surname>Vantieghem</surname><given-names>A.</given-names></name><name><surname>Merlevede</surname><given-names>W.</given-names></name><name><surname>de Witte</surname><given-names>P.</given-names></name></person-group><article-title>Hypericin in cancer treatment: More light on the way</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2002</year><volume>34</volume><fpage>221</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/S1357-2725(01)00126-1</pub-id><pub-id pub-id-type="pmid">11849990</pub-id></element-citation></ref><ref id="B138-molecules-25-05666"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buytaert</surname><given-names>E.</given-names></name><name><surname>Callewaert</surname><given-names>G.</given-names></name><name><surname>Hendrickx</surname><given-names>N.</given-names></name><name><surname>Scorrano</surname><given-names>L.</given-names></name><name><surname>Hartmann</surname><given-names>D.</given-names></name><name><surname>Missiaen</surname><given-names>L.</given-names></name><name><surname>Vandenheede</surname><given-names>J.R.</given-names></name><name><surname>Heirman</surname><given-names>I.</given-names></name><name><surname>Grooten</surname><given-names>J.</given-names></name><name><surname>Agostinis</surname><given-names>P.</given-names></name></person-group><article-title>Role of endoplasmic reticulum depletion and multidomain proapoptic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy</article-title><source>Faseb. J.</source><year>2006</year><volume>20</volume><fpage>756</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1096/fj.05-4305fje</pub-id><pub-id pub-id-type="pmid">16455754</pub-id></element-citation></ref><ref id="B139-molecules-25-05666"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrario</surname><given-names>A.</given-names></name><name><surname>von Tiehl</surname><given-names>K.</given-names></name><name><surname>Wong</surname><given-names>S.</given-names></name><name><surname>Luna</surname><given-names>M.</given-names></name><name><surname>Gomer</surname><given-names>C.J.</given-names></name></person-group><article-title>Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response</article-title><source>Cancer Res.</source><year>2002</year><volume>62</volume><fpage>3956</fpage><lpage>3961</lpage><pub-id pub-id-type="pmid">12124326</pub-id></element-citation></ref><ref id="B140-molecules-25-05666"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delcanale</surname><given-names>P.</given-names></name><name><surname>Pennacchietti</surname><given-names>F.</given-names></name><name><surname>Maestrini</surname><given-names>G.</given-names></name><name><surname>Rodr&#x000ed;guez-Amigo</surname><given-names>B.</given-names></name><name><surname>Bianchini</surname><given-names>P.</given-names></name><name><surname>Diaspro</surname><given-names>A.</given-names></name><name><surname>Iagatti</surname><given-names>A.</given-names></name><name><surname>Patrizi</surname><given-names>B.</given-names></name><name><surname>Foggi</surname><given-names>P.</given-names></name><name><surname>Agut</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Subdiffraction localization of a nanostructured photosensitizer in bacterial cells</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><fpage>15564</fpage><pub-id pub-id-type="doi">10.1038/srep15564</pub-id><?supplied-pmid 26494535?><pub-id pub-id-type="pmid">26494535</pub-id></element-citation></ref><ref id="B141-molecules-25-05666"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Sureau</surname><given-names>F.</given-names></name><name><surname>Chinsky</surname><given-names>L.</given-names></name><name><surname>Turpin</surname><given-names>P.Y.</given-names></name></person-group><article-title>Subcellular distribution of hypericin in human cancer cells</article-title><source>Photochem. Photobiol.</source><year>1995</year><volume>62</volume><fpage>546</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1995.tb02382.x</pub-id><pub-id pub-id-type="pmid">8570710</pub-id></element-citation></ref><ref id="B142-molecules-25-05666"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Chinsky</surname><given-names>L.</given-names></name><name><surname>Wheeler</surname><given-names>G.V.</given-names></name><name><surname>Turpin</surname><given-names>P.Y.</given-names></name></person-group><article-title>Hypericin site specific interactions within polynucleotides used as DNA model compounds</article-title><source>J. Biomol. Struct. Dyn.</source><year>1995</year><volume>13</volume><fpage>547</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1080/07391102.1995.10508865</pub-id><pub-id pub-id-type="pmid">8825735</pub-id></element-citation></ref><ref id="B143-molecules-25-05666"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;nchez-Cort&#x000e9;s</surname><given-names>S.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Jancura</surname><given-names>D.</given-names></name><name><surname>Bertoluzza</surname><given-names>A.</given-names></name></person-group><article-title>Specific interactions of antiretroviraly active drug hypericin with DNA as studied by surface-enhanced resonance Raman spectroscopy</article-title><source>J. Phys. Chem.</source><year>1996</year><volume>100</volume><fpage>1938</fpage><lpage>1944</lpage><pub-id pub-id-type="doi">10.1021/jp951980q</pub-id></element-citation></ref><ref id="B144-molecules-25-05666"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>K.</given-names></name><name><surname>Smirnov</surname><given-names>A.V.</given-names></name><name><surname>Wen</surname><given-names>J.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Petrich</surname><given-names>J.W.</given-names></name></person-group><article-title>Photophysics of hypericin and hypocrellin A in complex with subcellular components: Interactions with human serum albumin</article-title><source>Photochem. Photobiol.</source><year>1999</year><volume>69</volume><fpage>633</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1999.tb03339.x</pub-id><pub-id pub-id-type="pmid">10378001</pub-id></element-citation></ref><ref id="B145-molecules-25-05666"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senthil</surname><given-names>V.</given-names></name><name><surname>Jones</surname><given-names>L.R.</given-names></name><name><surname>Senthil</surname><given-names>K.</given-names></name><name><surname>Grossweiner</surname><given-names>L.J.</given-names></name></person-group><article-title>Hypericin photosensitization in aqueous model system</article-title><source>Photochem. Photobiol.</source><year>1994</year><volume>59</volume><fpage>40</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1111/j.1751-1097.1994.tb04999.x</pub-id><pub-id pub-id-type="pmid">8127939</pub-id></element-citation></ref><ref id="B146-molecules-25-05666"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mijatovic</surname><given-names>S.</given-names></name><name><surname>Maksimovic-Ivanic</surname><given-names>D.</given-names></name><name><surname>Radovic</surname><given-names>J.</given-names></name><name><surname>Milijkovic</surname><given-names>D.</given-names></name><name><surname>Kaludjerovic</surname><given-names>G.N.</given-names></name><name><surname>Sabo</surname><given-names>T.J.</given-names></name><name><surname>Trajkovic</surname><given-names>V.</given-names></name></person-group><article-title>Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin</article-title><source>Cell Mol. Life Sci.</source><year>2005</year><volume>62</volume><fpage>1275</fpage><lpage>1282</lpage><pub-id pub-id-type="doi">10.1007/s00018-005-5041-3</pub-id><?supplied-pmid 15905960?><pub-id pub-id-type="pmid">15905960</pub-id></element-citation></ref><ref id="B147-molecules-25-05666"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>T.</given-names></name><name><surname>Qi</surname><given-names>Q.H.</given-names></name><name><surname>Yang</surname><given-names>W.X.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>Z.L.</given-names></name></person-group><article-title>Contractile effects and antracellular Ca<sup>2+</sup> signaling induced by emodin in circular smooth muscle cells of rat colon</article-title><source>World J. Gastroenterol.</source><year>2003</year><volume>9</volume><fpage>1804</fpage><lpage>1807</lpage><pub-id pub-id-type="doi">10.3748/wjg.v9.i8.1804</pub-id><?supplied-pmid 12918125?><pub-id pub-id-type="pmid">12918125</pub-id></element-citation></ref><ref id="B148-molecules-25-05666"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janeczko</surname><given-names>M.</given-names></name><name><surname>Mas&#x0010d;yk</surname><given-names>M.</given-names></name><name><surname>Kubi&#x00144;ski</surname><given-names>K.</given-names></name><name><surname>Golczyk</surname><given-names>H.</given-names></name></person-group><article-title>Emodin, a natural inhibitor of protein kinase CK2, suppresses growth, hyphal development, and biofilm formation of Candida Albicans</article-title><source>Yeast</source><year>2017</year><volume>34</volume><fpage>253</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1002/yea.3230</pub-id><pub-id pub-id-type="pmid">28181315</pub-id></element-citation></ref><ref id="B149-molecules-25-05666"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.C.</given-names></name><name><surname>Lee</surname><given-names>C.R.</given-names></name><name><surname>Lee Chao</surname><given-names>P.D.</given-names></name><name><surname>Chen</surname><given-names>C.C.</given-names></name><name><surname>Chu</surname><given-names>S.H.</given-names></name></person-group><article-title>Vasorelaxant effects of emodin, an antraquinone from a Chinese herb</article-title><source>Eur. J. Pharmacol.</source><year>1991</year><volume>205</volume><fpage>289</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">1667913</pub-id></element-citation></ref><ref id="B150-molecules-25-05666"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.T.</given-names></name><name><surname>Chang</surname><given-names>H.L.</given-names></name><name><surname>Shyue</surname><given-names>S.K.</given-names></name><name><surname>Hsu</surname><given-names>S.L.</given-names></name></person-group><article-title>Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway</article-title><source>Biochem. Pharmacol.</source><year>2005</year><volume>70</volume><fpage>229</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2005.04.026</pub-id><?supplied-pmid 15941563?><pub-id pub-id-type="pmid">15941563</pub-id></element-citation></ref><ref id="B151-molecules-25-05666"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chukwujelwu</surname><given-names>J.C.</given-names></name><name><surname>Coombes</surname><given-names>P.H.</given-names></name><name><surname>Mulholland</surname><given-names>D.A.</given-names></name><name><surname>van Staden</surname><given-names>J.</given-names></name></person-group><article-title>Emodin, an antibacterial anthraquinone from the roots of Cassia occidentalis</article-title><source>S. Afr. J. Bot.</source><year>2006</year><volume>72</volume><fpage>295</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2005.08.003</pub-id></element-citation></ref><ref id="B152-molecules-25-05666"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivas</surname><given-names>G.</given-names></name><name><surname>Babykutty</surname><given-names>S.</given-names></name><name><surname>Sathiadevan</surname><given-names>P.P.</given-names></name><name><surname>Srinivas</surname><given-names>P.</given-names></name></person-group><article-title>Molecular mechanism of emodin action: Transition from laxative ingredient to an antitumor agent</article-title><source>Med. Res. Rev.</source><year>2007</year><volume>27</volume><fpage>591</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1002/med.20095</pub-id><?supplied-pmid 17019678?><pub-id pub-id-type="pmid">17019678</pub-id></element-citation></ref><ref id="B153-molecules-25-05666"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernand</surname><given-names>V.E.</given-names></name><name><surname>Dinh</surname><given-names>D.T.</given-names></name><name><surname>Washington</surname><given-names>S.J.</given-names></name><name><surname>Fakayode</surname><given-names>S.O.</given-names></name><name><surname>Loss</surname><given-names>J.N.</given-names></name><name><surname>van Ravenswaay</surname><given-names>R.O.</given-names></name><name><surname>Warner</surname><given-names>I.M.</given-names></name></person-group><article-title>Determination of pharmacologically active compounds in root extracts of Cassia Alata L. by use of high performance liquid chromatography</article-title><source>Talanta</source><year>2008</year><volume>74</volume><fpage>896</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1016/j.talanta.2007.07.033</pub-id><pub-id pub-id-type="pmid">18371725</pub-id></element-citation></ref><ref id="B154-molecules-25-05666"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hennebelle</surname><given-names>T.</given-names></name><name><surname>Weniger</surname><given-names>B.</given-names></name><name><surname>Joseph</surname><given-names>H.</given-names></name><name><surname>Sahpaz</surname><given-names>S.</given-names></name><name><surname>Bailleul</surname><given-names>F.</given-names></name></person-group><article-title>Senna alata</article-title><source>Fitoterapia</source><year>2009</year><volume>80</volume><fpage>385</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2009.05.008</pub-id><pub-id pub-id-type="pmid">19446609</pub-id></element-citation></ref><ref id="B155-molecules-25-05666"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>D.O.</given-names></name><name><surname>Weber</surname><given-names>N.D.</given-names></name><name><surname>Wood</surname><given-names>S.G.</given-names></name><name><surname>Hughes</surname><given-names>B.G.</given-names></name><name><surname>Murray</surname><given-names>B.K.</given-names></name><name><surname>North</surname><given-names>J.A.</given-names></name></person-group><article-title>In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives</article-title><source>Antiviral Res.</source><year>1991</year><volume>16</volume><fpage>185</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/0166-3542(91)90024-L</pub-id><pub-id pub-id-type="pmid">1665961</pub-id></element-citation></ref><ref id="B156-molecules-25-05666"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusari</surname><given-names>S.</given-names></name><name><surname>Lamsh&#x000f6;ft</surname><given-names>M.</given-names></name><name><surname>Z&#x000fc;hlke</surname><given-names>S.</given-names></name><name><surname>Spiteller</surname><given-names>M.</given-names></name></person-group><article-title>An endophytic fungus from hypericum perforatum that produces hypericin</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>159</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1021/np070669k</pub-id><?supplied-pmid 18220354?><pub-id pub-id-type="pmid">18220354</pub-id></element-citation></ref><ref id="B157-molecules-25-05666"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karioti</surname><given-names>A.</given-names></name><name><surname>Bilia</surname><given-names>A.R.</given-names></name></person-group><article-title>Hypericins as potential leads for new therapeutics</article-title><source>Int. J. Mol. Sci.</source><year>2010</year><volume>11</volume><fpage>562</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.3390/ijms11020562</pub-id><?supplied-pmid 20386655?><pub-id pub-id-type="pmid">20386655</pub-id></element-citation></ref><ref id="B158-molecules-25-05666"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanska</surname><given-names>A.</given-names></name><name><surname>Chmurzy&#x00144;ski</surname><given-names>L.</given-names></name><name><surname>Ossowski</surname><given-names>T.</given-names></name><name><surname>Liwo</surname><given-names>A.</given-names></name><name><surname>Jeziorek</surname><given-names>D.</given-names></name></person-group><article-title>Protolytic equilibria of dihydroxyanthraquinones in non-aqueous solutions</article-title><source>Anal. Chim. Acta</source><year>1999</year><volume>402</volume><fpage>339</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/S0003-2670(99)00546-2</pub-id></element-citation></ref><ref id="B159-molecules-25-05666"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>S.O.</given-names></name><name><surname>Lutz</surname><given-names>W.K.</given-names></name><name><surname>Stopper</surname><given-names>H.</given-names></name></person-group><article-title>Factors affecting the genotoxic potency ranking of natural anthraquinones in mammalian cell culture systems</article-title><source>Mutat. Res.</source><year>1998</year><volume>414</volume><fpage>125</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/S1383-5718(98)00047-3</pub-id><pub-id pub-id-type="pmid">9630566</pub-id></element-citation></ref><ref id="B160-molecules-25-05666"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name></person-group><article-title>Effects of emodin on the activity of K channel in guinea pig taenia coli smooth muscle cells</article-title><source>Acta Pharm. Sin.</source><year>1998</year><volume>33</volume><fpage>321</fpage><lpage>325</lpage></element-citation></ref><ref id="B161-molecules-25-05666"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>T.</given-names></name><name><surname>Qi</surname><given-names>Q.H.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>Z.L.</given-names></name><name><surname>Yang</surname><given-names>W.X.</given-names></name></person-group><article-title>Signal pathways involved in emodin-induced contraction of smooth muscle cells from rat colon</article-title><source>World J. Gastroenterol.</source><year>2004</year><volume>10</volume><fpage>1476</fpage><lpage>1479</lpage><pub-id pub-id-type="doi">10.3748/wjg.v10.i10.1476</pub-id><?supplied-pmid 15133857?><pub-id pub-id-type="pmid">15133857</pub-id></element-citation></ref><ref id="B162-molecules-25-05666"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>D.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Lv</surname><given-names>B.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name></person-group><article-title>Characteristics of emodin on modulating the contractility of jejunal smooth muscle</article-title><source>Can. J. Physiol. Pharmacol.</source><year>2012</year><volume>90</volume><fpage>455</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1139/y2012-004</pub-id><pub-id pub-id-type="pmid">22452333</pub-id></element-citation></ref><ref id="B163-molecules-25-05666"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>F.</given-names></name><name><surname>Fraile</surname><given-names>G.</given-names></name><name><surname>Vel&#x000e1;squez</surname><given-names>M.</given-names></name><name><surname>Correia</surname><given-names>H.</given-names></name><name><surname>Fonseca</surname><given-names>G.</given-names></name><name><surname>Marin</surname><given-names>M.</given-names></name><name><surname>Marcano</surname><given-names>E.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>Y.</given-names></name></person-group><article-title>Studies on the photostability and phototoxicity of aloe-emodin, emodin and rhein</article-title><source>Pharmazie</source><year>2002</year><volume>57</volume><fpage>399</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">12116877</pub-id></element-citation></ref><ref id="B164-molecules-25-05666"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oshida</surname><given-names>K.</given-names></name><name><surname>Hirakata</surname><given-names>M.</given-names></name><name><surname>Maeda</surname><given-names>A.</given-names></name><name><surname>Miyoshi</surname><given-names>T.</given-names></name><name><surname>Miyamoto</surname><given-names>Y.</given-names></name></person-group><article-title>Toxicological effect of emodin in mouse testicular gene expression profile</article-title><source>J. Appl. Toxicol.</source><year>2011</year><volume>31</volume><fpage>790</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1002/jat.1637</pub-id><pub-id pub-id-type="pmid">21319176</pub-id></element-citation></ref><ref id="B165-molecules-25-05666"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Toselli</surname><given-names>A.</given-names></name><name><surname>Russell</surname><given-names>L.D.</given-names></name><name><surname>Seldin</surname><given-names>D.C.</given-names></name></person-group><article-title>Globozospermia in mice lacking the casein kinase II &#x003b1;&#x000b4;catalytic subunit</article-title><source>Nat. Genet.</source><year>1999</year><volume>23</volume><fpage>118</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1038/12729</pub-id><?supplied-pmid 10471512?><pub-id pub-id-type="pmid">10471512</pub-id></element-citation></ref><ref id="B166-molecules-25-05666"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escalier</surname><given-names>D.</given-names></name><name><surname>Silvius</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title>Spermatogenesis of mice lacking CK2alpha&#x000b4;failure of germ cell survival and characteristic modifications of the spermatid nucleus</article-title><source>Mol. Reprod. Dev.</source><year>2003</year><volume>66</volume><fpage>190</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1002/mrd.10346</pub-id><?supplied-pmid 12950107?><pub-id pub-id-type="pmid">12950107</pub-id></element-citation></ref><ref id="B167-molecules-25-05666"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Ye</surname><given-names>B.</given-names></name></person-group><article-title>Electrochemical studies of the interaction of the anticancer herbal drug emodin with DNA</article-title><source>J. Pharm. Biomed. Anal.</source><year>2006</year><volume>42</volume><fpage>625</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2006.05.017</pub-id><?supplied-pmid 16828249?><pub-id pub-id-type="pmid">16828249</pub-id></element-citation></ref><ref id="B168-molecules-25-05666"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Qiao</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name></person-group><article-title>Studies of interaction of emodin and DNA in the presence of ethidium bromide by spectroscopic method</article-title><source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source><year>2008</year><volume>69</volume><fpage>123</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.saa.2007.03.017</pub-id><?supplied-pmid 17548242?><pub-id pub-id-type="pmid">17548242</pub-id></element-citation></ref><ref id="B169-molecules-25-05666"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>S.T.</given-names></name><name><surname>Silva</surname><given-names>G.</given-names></name><name><surname>Pungartnik</surname><given-names>C.</given-names></name><name><surname>Brendel</surname><given-names>M.</given-names></name></person-group><article-title>Study of DNA-emodin interaction by FTIR and UV-Vis spectroscopy</article-title><source>J. Photochem. Photobiol. B: Biol.</source><year>2012</year><volume>111</volume><fpage>59</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2012.03.012</pub-id></element-citation></ref><ref id="B170-molecules-25-05666"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Luan</surname><given-names>Y.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Gong</surname><given-names>L.</given-names></name><name><surname>Xue</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Xing</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II</article-title><source>Toxicol. Sci.</source><year>2010</year><volume>118</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfq282</pub-id><pub-id pub-id-type="pmid">20855424</pub-id></element-citation></ref><ref id="B171-molecules-25-05666"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabriciova</surname><given-names>G.</given-names></name><name><surname>Sanchez-Cortes</surname><given-names>S.</given-names></name><name><surname>Garcia-Ramos</surname><given-names>J.V.</given-names></name><name><surname>Miskovsky</surname><given-names>P.</given-names></name></person-group><article-title>Surface-enhanced Raman spectroscopy study of the interaction of the antitumoral drug emodin with serum albumin</article-title><source>Biopolymers</source><year>2004</year><volume>74</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1002/bip.20058</pub-id><pub-id pub-id-type="pmid">15137109</pub-id></element-citation></ref><ref id="B172-molecules-25-05666"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>S.Y.</given-names></name><name><surname>Song</surname><given-names>D.O.</given-names></name><name><surname>Kan</surname><given-names>Y.H.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>H.Q.</given-names></name></person-group><article-title>Spectroscopic characterization of effective components anthraquinones in Chinese medicinal herbs binding with serum albumins</article-title><source>Spectrochim. Acta A: Biomol. Spectrosc.</source><year>2005</year><volume>62</volume><fpage>203</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.saa.2004.12.049</pub-id></element-citation></ref><ref id="B173-molecules-25-05666"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koistinen</surname><given-names>K.M.</given-names></name><name><surname>Soininen</surname><given-names>P.</given-names></name><name><surname>Venalainen</surname><given-names>T.A.</given-names></name><name><surname>Hayrinen</surname><given-names>J.</given-names></name><name><surname>Laatikainen</surname><given-names>R.</given-names></name><name><surname>Perakyla</surname><given-names>M.</given-names></name><name><surname>Tervahauta</surname><given-names>A.I.</given-names></name><name><surname>Karenlampi</surname><given-names>S.O.</given-names></name></person-group><article-title>Birch PR-10c interacts with several biologically important ligands</article-title><source>Phytochemistry</source><year>2005</year><volume>66</volume><fpage>2524</fpage><lpage>2533</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2005.09.007</pub-id><pub-id pub-id-type="pmid">16246382</pub-id></element-citation></ref><ref id="B174-molecules-25-05666"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sevilla</surname><given-names>P.</given-names></name><name><surname>Rivas</surname><given-names>J.M.</given-names></name><name><surname>Garc&#x000ed;a-Blanco</surname><given-names>F.</given-names></name><name><surname>Garc&#x000ed;a-Ramos</surname><given-names>J.V.</given-names></name><name><surname>S&#x000e1;nchez-Cort&#x000e9;s</surname><given-names>S.</given-names></name></person-group><article-title>Identification of the antitumoral drug emodin binding sites in bovine serum albumin by spectroscopic methods</article-title><source>BBA-Proteins Proteom.</source><year>2007</year><volume>1774</volume><fpage>1359</fpage><lpage>1369</lpage><pub-id pub-id-type="doi">10.1016/j.bbapap.2007.07.022</pub-id></element-citation></ref><ref id="B175-molecules-25-05666"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pecere</surname><given-names>T.</given-names></name><name><surname>Gazzola</surname><given-names>M.V.</given-names></name><name><surname>Mucignat</surname><given-names>C.</given-names></name><name><surname>Parolin</surname><given-names>C.</given-names></name><name><surname>Dalla</surname><given-names>V.F.</given-names></name><name><surname>Cavaggioni</surname><given-names>A.</given-names></name><name><surname>Basso</surname><given-names>G.</given-names></name><name><surname>Diaspro</surname><given-names>A.</given-names></name><name><surname>Salvato</surname><given-names>B.</given-names></name><name><surname>Carli</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors</article-title><source>Cancer Res.</source><year>2000</year><volume>60</volume><fpage>2800</fpage><lpage>2804</lpage><pub-id pub-id-type="pmid">10850417</pub-id></element-citation></ref><ref id="B176-molecules-25-05666"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun-Guan</surname><given-names>W.</given-names></name><name><surname>Jun-Qing</surname><given-names>Y.</given-names></name><name><surname>Bei-Zhong</surname><given-names>L.</given-names></name><name><surname>Dan-Ting</surname><given-names>J.</given-names></name><name><surname>Chong</surname><given-names>W.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Dan</surname><given-names>Z.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name></person-group><article-title>Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo</article-title><source>Eur. J. Pharmacol.</source><year>2010</year><volume>627</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.10.035</pub-id><?supplied-pmid 19857484?><pub-id pub-id-type="pmid">19857484</pub-id></element-citation></ref><ref id="B177-molecules-25-05666"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>T.C.</given-names></name><name><surname>Yang</surname><given-names>J.S.</given-names></name><name><surname>Lin</surname><given-names>M.W.</given-names></name><name><surname>Hsu</surname><given-names>S.C.</given-names></name><name><surname>Lin</surname><given-names>J.J.</given-names></name><name><surname>Lin</surname><given-names>H.J.</given-names></name><name><surname>Hsia</surname><given-names>T.C.</given-names></name><name><surname>Liao</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>M.D.</given-names></name><name><surname>Fan</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Emodin has cytotoxic and pretoctive effect in rat c6 glioma cells: Roles of Mdr1a and nuclear factor &#x003ba;B in cell survival</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2009</year><volume>330</volume><fpage>736</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1124/jpet.109.153007</pub-id><?supplied-pmid 19549930?><pub-id pub-id-type="pmid">19549930</pub-id></element-citation></ref><ref id="B178-molecules-25-05666"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>J.C.</given-names></name><name><surname>Su</surname><given-names>Y.J.</given-names></name><name><surname>Lin</surname><given-names>S.T.</given-names></name><name><surname>Jhan</surname><given-names>J.Y.</given-names></name><name><surname>Ciou</surname><given-names>S.C.</given-names></name><name><surname>Cheng</surname><given-names>C.M.</given-names></name><name><surname>Lin</surname><given-names>Y.W.</given-names></name></person-group><article-title>Suppression of ERCC1 and Rad51 expression through ER1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells</article-title><source>Biochem. Pharmacol.</source><year>2010</year><volume>79</volume><fpage>655</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2009.09.024</pub-id><?supplied-pmid 19799875?><pub-id pub-id-type="pmid">19799875</pub-id></element-citation></ref><ref id="B179-molecules-25-05666"><label>179.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>Chemicalland21</collab></person-group><article-title>Quinizarin</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.chemicalland21.com/specialtychem/finechem/QUINIZARIN.htm">http://www.chemicalland21.com/specialtychem/finechem/QUINIZARIN.htm</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-09-07">(accessed on 7 September 2020)</date-in-citation></element-citation></ref><ref id="B180-molecules-25-05666"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinti</surname><given-names>L.</given-names></name><name><surname>Allen</surname><given-names>N.S.</given-names></name><name><surname>Edge</surname><given-names>M.</given-names></name><name><surname>Murphy</surname><given-names>B.P.</given-names></name><name><surname>Perotti</surname><given-names>A.</given-names></name></person-group><article-title>A study of the strongly fluorescent species formed by the interaction of the dye 1,4-dihydroxyanthraquinone (quinizarin) with A(III)</article-title><source>J. Photochem. Photobiol. A Chem.</source><year>2003</year><volume>155</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/S1010-6030(02)00360-X</pub-id></element-citation></ref><ref id="B181-molecules-25-05666"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yohida</surname><given-names>M.</given-names></name></person-group><article-title>Chemistry and hair dyes application of dihydroxy derivates of anthraquinone and naphtoquinone</article-title><source>Prog. Org. Coat.</source><year>1997</year><volume>31</volume><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/S0300-9440(97)00019-2</pub-id></element-citation></ref><ref id="B182-molecules-25-05666"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinkworth</surname><given-names>R.I.</given-names></name><name><surname>Fairle</surname><given-names>D.P.</given-names></name></person-group><article-title>Hydroxyquinones are competitive nonpeptide inhibitors of HIV-1 proteinase</article-title><source>Biochim. Biophys. Acta</source><year>1995</year><volume>1253</volume><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/0167-4838(95)00183-U</pub-id><pub-id pub-id-type="pmid">7492599</pub-id></element-citation></ref><ref id="B183-molecules-25-05666"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>J.P.</given-names></name></person-group><article-title>A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds</article-title><source>Mutat. Res.</source><year>1980</year><volume>75</volume><fpage>243</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/0165-1110(80)90029-9</pub-id><pub-id pub-id-type="pmid">6770263</pub-id></element-citation></ref><ref id="B184-molecules-25-05666"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>V.</given-names></name><name><surname>Amato</surname><given-names>G.</given-names></name><name><surname>Salvetti</surname><given-names>A.</given-names></name><name><surname>Gervasi</surname><given-names>P.G.</given-names></name></person-group><article-title>Heterogenous effect of anthraquinones on drug-metabolizing enzymes in the liver and small intestine of rat</article-title><source>Chem. Biol. Interact.</source><year>2000</year><volume>126</volume><fpage>63</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/S0009-2797(00)00154-X</pub-id><pub-id pub-id-type="pmid">10826654</pub-id></element-citation></ref><ref id="B185-molecules-25-05666"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>T.P.</given-names></name><name><surname>Gillispie</surname><given-names>G.D.</given-names></name><name><surname>Connoll</surname><given-names>M.A.</given-names></name></person-group><article-title>Intramolecular hydrogen bonding in substituted anthraquinones by laser-induced fluorescence. 1. 1,4-dihydroxyanthraquinone (quinizarin)</article-title><source>J. Phys. Chem.</source><year>1982</year><volume>86</volume><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1021/j100391a012</pub-id></element-citation></ref><ref id="B186-molecules-25-05666"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smulevich</surname><given-names>G.</given-names></name><name><surname>Angeloni</surname><given-names>L.</given-names></name><name><surname>Giovannardi</surname><given-names>S.</given-names></name><name><surname>Marzocchi</surname><given-names>M.P.</given-names></name></person-group><article-title>Resonance Raman and polarized light infrared spectra of 1,4-dihydroxyanthraquinone, vibrational studies of the ground and excited electronic states</article-title><source>Chem. Phys.</source><year>1982</year><volume>65</volume><fpage>313</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/0301-0104(82)85207-5</pub-id></element-citation></ref><ref id="B187-molecules-25-05666"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nigam</surname><given-names>G.</given-names></name><name><surname>Deppisch</surname><given-names>B.</given-names></name></person-group><article-title>Redetermination of the structure of 1,4-dihydroxyanthraquinone (C<sub>14</sub>H<sub>8</sub>O<sub>4</sub>)</article-title><source>Z. Kristallogr.</source><year>1980</year><volume>151</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1524/zkri.1980.151.3-4.185</pub-id></element-citation></ref><ref id="B188-molecules-25-05666"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabriciov&#x000e1;</surname><given-names>G.</given-names></name><name><surname>Garcia-Ramos</surname><given-names>J.V.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Sanchez-Cortes</surname><given-names>S.</given-names></name></person-group><article-title>Absorption and acidic behavior of anthraquinone drugs quinizarin and danthron on Ag nanoparticles studied by Raman spectroscopy</article-title><source>Vib. Spectrosc.</source><year>2004</year><volume>34</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.vibspec.2004.01.001</pub-id></element-citation></ref><ref id="B189-molecules-25-05666"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bondy</surname><given-names>G.S.</given-names></name><name><surname>Armstrong</surname><given-names>C.L.</given-names></name><name><surname>Dawson</surname><given-names>B.A.</given-names></name><name><surname>H&#x000e9;roux-Metcalf</surname><given-names>C.</given-names></name><name><surname>Neville</surname><given-names>G.A.</given-names></name><name><surname>Rogers</surname><given-names>C.G.</given-names></name></person-group><article-title>Toxicity of structurally related anthraquinones and anthrones to mammalian-cell in vitro</article-title><source>Toxicol. In Vitro</source><year>1994</year><volume>8</volume><fpage>329</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/0887-2333(94)90153-8</pub-id><pub-id pub-id-type="pmid">20692923</pub-id></element-citation></ref><ref id="B190-molecules-25-05666"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verebov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Adam&#x0010d;&#x000ed;k</surname><given-names>J.</given-names></name><name><surname>Danko</surname><given-names>P.</given-names></name><name><surname>Podhradsk&#x000fd;</surname><given-names>D.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name><name><surname>Stani&#x0010d;ov&#x000e1;</surname><given-names>J.</given-names></name></person-group><article-title>Anthraquinones quinizarine and danthron unwind negatively supercoiled DNA and lengthen linear DNA</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2014</year><volume>444</volume><fpage>50</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2014.01.007</pub-id><?supplied-pmid 24434150?><pub-id pub-id-type="pmid">24434150</pub-id></element-citation></ref><ref id="B191-molecules-25-05666"><label>191.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>IARC</collab></person-group><article-title>Dantron (chrysazin; 1,8-dihydroxyanthraquinone)</article-title><source>Pharmaceutical Drugs</source><publisher-name>International Agency for Research on Cancer</publisher-name><publisher-loc>Lyon, France</publisher-loc><year>1990</year><fpage>265</fpage><lpage>275</lpage></element-citation></ref><ref id="B192-molecules-25-05666"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>S.O.</given-names></name><name><surname>Stopper</surname><given-names>H.</given-names></name><name><surname>Dekant</surname><given-names>W.</given-names></name></person-group><article-title>biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites</article-title><source>Drug Metab. Dispos.</source><year>1998</year><volume>26</volume><fpage>540</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">9616189</pub-id></element-citation></ref><ref id="B193-molecules-25-05666"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;ller</surname><given-names>S.O.</given-names></name><name><surname>Eckert</surname><given-names>I.</given-names></name><name><surname>Lutz</surname><given-names>W.K.</given-names></name><name><surname>Stopper</surname><given-names>H.</given-names></name></person-group><article-title>Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated</article-title><source>Mutat. Res. Genet. Toxicol.</source><year>1996</year><volume>371</volume><fpage>165</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/S0165-1218(96)90105-6</pub-id></element-citation></ref><ref id="B194-molecules-25-05666"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downes</surname><given-names>C.S.</given-names></name><name><surname>Mullinger</surname><given-names>A.M.</given-names></name><name><surname>Johnson</surname><given-names>R.T.</given-names></name></person-group><article-title>Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalians cells but do not prevent exit from mitosis</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1991</year><volume>88</volume><fpage>8895</fpage><lpage>8899</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.20.8895</pub-id><pub-id pub-id-type="pmid">1656458</pub-id></element-citation></ref><ref id="B195-molecules-25-05666"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.R.</given-names></name><name><surname>Caron</surname><given-names>P.R.</given-names></name><name><surname>Kim</surname><given-names>R.A.</given-names></name></person-group><article-title>The role of DNA topoisomerases in recombination and genomic stability: A double-edged sword</article-title><source>Cell</source><year>1990</year><volume>62</volume><fpage>403</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(90)90002-V</pub-id><pub-id pub-id-type="pmid">2165864</pub-id></element-citation></ref><ref id="B196-molecules-25-05666"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neimeikait&#x000e9;-&#x0010c;&#x000e9;nien&#x000e9;</surname><given-names>A.</given-names></name><name><surname>Sergedien&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Nivinskas</surname><given-names>H.</given-names></name><name><surname>&#x0010c;&#x000e9;nas</surname><given-names>N.</given-names></name></person-group><article-title>Cytotoxicity of natural hydroxyanthraquinones: Role of oxidative stress</article-title><source>Z. Naturforsch. C</source><year>2002</year><volume>57</volume><fpage>822</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1515/znc-2002-9-1012</pub-id><pub-id pub-id-type="pmid">12440719</pub-id></element-citation></ref><ref id="B197-molecules-25-05666"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>D.F.</given-names></name><name><surname>Fink</surname><given-names>R.C.</given-names></name><name><surname>Schaefer</surname><given-names>F.L.</given-names></name><name><surname>Mulcahy</surname><given-names>R.J.</given-names></name><name><surname>Stark</surname><given-names>A.</given-names></name></person-group><article-title>Mutagenicity of anthraquinone and hydroxylated anthraquinones in the Ames/Salmonella microsome system</article-title><source>Appl. Environ. Microbiol.</source><year>1982</year><volume>43</volume><fpage>1354</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1128/AEM.43.6.1354-1359.1982</pub-id><pub-id pub-id-type="pmid">7103489</pub-id></element-citation></ref><ref id="B198-molecules-25-05666"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreiro</surname><given-names>M.L.</given-names></name><name><surname>Rodriguez-Otero</surname><given-names>J.</given-names></name></person-group><article-title>Ab inition study of the intramolecular proton transfer in dihydroxyanthraquinones</article-title><source>J. Mol. Struct.</source><year>2001</year><volume>542</volume><fpage>63</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/S0166-1280(00)00811-3</pub-id></element-citation></ref><ref id="B199-molecules-25-05666"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>S.S.</given-names></name><name><surname>Khan</surname><given-names>R.H.</given-names></name><name><surname>Naqvi</surname><given-names>S.</given-names></name></person-group><article-title>Probing the intermolecular interactions into serum albumin and anthraquinone systems: A spectroscopic and docking approach</article-title><source>J. Biomol. Struct. Dyn.</source><year>2018</year><volume>36</volume><fpage>3362</fpage><lpage>3375</lpage><pub-id pub-id-type="doi">10.1080/07391102.2017.1388284</pub-id><?supplied-pmid 28974158?><pub-id pub-id-type="pmid">28974158</pub-id></element-citation></ref><ref id="B200-molecules-25-05666"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jutkova</surname><given-names>A.</given-names></name><name><surname>Chorvat</surname><given-names>D.</given-names></name><name><surname>Miskovsky</surname><given-names>P.</given-names></name><name><surname>Jancura</surname><given-names>D.</given-names></name><name><surname>Datta</surname><given-names>S.</given-names></name></person-group><article-title>Encapsulation of anticancer drug curcumin and co-loading with photosensitizer hypericin into lipoproteins investigated by fluorescence resonance energy transfer</article-title><source>Int. J. Pharm.</source><year>2019</year><volume>564</volume><fpage>369</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2019.04.062</pub-id><?supplied-pmid 31022501?><pub-id pub-id-type="pmid">31022501</pub-id></element-citation></ref><ref id="B201-molecules-25-05666"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozsup</surname><given-names>M.</given-names></name><name><surname>D&#x000f6;m&#x000f6;t&#x000f6;r</surname><given-names>O.</given-names></name><name><surname>Nagy</surname><given-names>S.</given-names></name><name><surname>Farkas</surname><given-names>E.</given-names></name><name><surname>Enyedy</surname><given-names>E.A.</given-names></name><name><surname>Bugly&#x000f3;</surname><given-names>P.</given-names></name></person-group><article-title>Synthesis, characterization and albumin binding capabilities of quinizarin containing ternary cobalt(III) complexes</article-title><source>J. Inorg. Biochem.</source><year>2020</year><volume>204</volume><fpage>110963</fpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2019.110963</pub-id><pub-id pub-id-type="pmid">31874363</pub-id></element-citation></ref><ref id="B202-molecules-25-05666"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crlikova</surname><given-names>H.</given-names></name><name><surname>Kostrhunova</surname><given-names>H.</given-names></name><name><surname>Pracharova</surname><given-names>J.</given-names></name><name><surname>Kozsup</surname><given-names>M.</given-names></name><name><surname>Nagy</surname><given-names>S.</given-names></name><name><surname>Bugly&#x000f3;</surname><given-names>P.</given-names></name><name><surname>Brabec</surname><given-names>V.</given-names></name><name><surname>Kasparkova</surname><given-names>J.</given-names></name></person-group><article-title>Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligand</article-title><source>J. Biol. Inorg. Chem.</source><year>2020</year><volume>25</volume><fpage>339</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1007/s00775-020-01765-4</pub-id><pub-id pub-id-type="pmid">32112290</pub-id></element-citation></ref><ref id="B203-molecules-25-05666"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko&#x0010d;i&#x00161;ov&#x000e1;</surname><given-names>E.</given-names></name><name><surname>Chinsky</surname><given-names>L.</given-names></name><name><surname>Mi&#x00161;kovsk&#x000fd;</surname><given-names>P.</given-names></name></person-group><article-title>Sequence specific interaction of the photoactive drug hypericin depends on the structural arrangement and the stability of the structure containing its specific 5&#x000b4;AG3&#x000b4;target: A resonance Raman spectroscopy study</article-title><source>J. Biomol. Struct. Dyn.</source><year>1999</year><volume>17</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1080/07391102.1999.10508340</pub-id><pub-id pub-id-type="pmid">10496421</pub-id></element-citation></ref><ref id="B204-molecules-25-05666"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stani&#x0010d;ov&#x000e1;</surname><given-names>J.</given-names></name><name><surname>Verebov&#x000e1;</surname><given-names>V.</given-names></name><name><surname>Strej&#x0010d;kov&#x000e1;</surname><given-names>A.</given-names></name></person-group><article-title>Potential anticancer agent hypericin and its model compound emodin: Interaction with DNA</article-title><source>&#x0010c;es. Slov. Farm.</source><year>2016</year><volume>65</volume><fpage>28</fpage><lpage>31</lpage></element-citation></ref><ref id="B205-molecules-25-05666"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottesman</surname><given-names>M.M.</given-names></name><name><surname>Fojo</surname><given-names>T.</given-names></name><name><surname>Bates</surname><given-names>S.E.</given-names></name></person-group><article-title>Multidrug resistance in cancer: Role of ATP-dependent transporters</article-title><source>Nat. Rev. Cancer</source><year>2002</year><volume>2</volume><fpage>48</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/nrc706</pub-id><pub-id pub-id-type="pmid">11902585</pub-id></element-citation></ref><ref id="B206-molecules-25-05666"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>S.G.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Ward</surname><given-names>A.</given-names></name><name><surname>Weng</surname><given-names>Y.</given-names></name><name><surname>Chittaboina</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>R.P.</given-names></name><name><surname>Harrell</surname><given-names>P.M.</given-names></name><name><surname>Trinh</surname><given-names>Y.T.</given-names></name><name><surname>Zhang</surname><given-names>Q.H.</given-names></name><name><surname>Urbatsch</surname><given-names>I.L.</given-names></name><etal/></person-group><article-title>Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding</article-title><source>Science</source><year>2009</year><volume>323</volume><fpage>1718</fpage><lpage>1722</lpage><pub-id pub-id-type="doi">10.1126/science.1168750</pub-id><pub-id pub-id-type="pmid">19325113</pub-id></element-citation></ref><ref id="B207-molecules-25-05666"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regina</surname><given-names>A.</given-names></name><name><surname>Demeule</surname><given-names>M.</given-names></name><name><surname>Laplante</surname><given-names>A.</given-names></name><name><surname>Jodoin</surname><given-names>J.</given-names></name><name><surname>Dagenais</surname><given-names>C.</given-names></name><name><surname>Berthelet</surname><given-names>F.</given-names></name><name><surname>Moghrabi</surname><given-names>A.</given-names></name><name><surname>Beliveau</surname><given-names>R.</given-names></name></person-group><article-title>Multidrug resistance in brain tumors: Roles of the blood-brain barrier</article-title><source>Cancer Metastasis Rev.</source><year>2001</year><volume>20</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1023/A:1013104423154</pub-id><pub-id pub-id-type="pmid">11831641</pub-id></element-citation></ref><ref id="B208-molecules-25-05666"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szaflarski</surname><given-names>W.</given-names></name><name><surname>Sujka-Kordowska</surname><given-names>P.</given-names></name><name><surname>Januchowski</surname><given-names>R.</given-names></name><name><surname>Wojtowicz</surname><given-names>K.</given-names></name><name><surname>Andrzejewska</surname><given-names>M.</given-names></name><name><surname>Nowicki</surname><given-names>M.</given-names></name><name><surname>Zabel</surname><given-names>M.</given-names></name></person-group><article-title>Nuclear localization of P-glycoprotein is responsible for protection of the nucleus from doxorubicin in the resistant LoVo cell line</article-title><source>Biomed. Pharmacother.</source><year>2013</year><volume>67</volume><fpage>497</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2013.03.011</pub-id><?supplied-pmid 23602050?><pub-id pub-id-type="pmid">23602050</pub-id></element-citation></ref><ref id="B209-molecules-25-05666"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weyergang</surname><given-names>A.</given-names></name><name><surname>Berstad</surname><given-names>M.E.</given-names></name><name><surname>Bull-Hansen</surname><given-names>B.</given-names></name><name><surname>Olsen</surname><given-names>C.E.</given-names></name><name><surname>Selbo</surname><given-names>P.K.</given-names></name><name><surname>Berg</surname><given-names>K.</given-names></name></person-group><article-title>Photochemical activation of drug for the treatment of therapy-resistant cancers</article-title><source>Photochem. Photobiol. Sci.</source><year>2015</year><volume>14</volume><fpage>1465</fpage><lpage>1475</lpage><pub-id pub-id-type="doi">10.1039/C5PP00029G</pub-id><?supplied-pmid 25849953?><pub-id pub-id-type="pmid">25849953</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-05666-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Scheme of photodynamic therapy (PDT; edited by [<xref rid="B42-molecules-25-05666" ref-type="bibr">42</xref>,<xref rid="B43-molecules-25-05666" ref-type="bibr">43</xref>]).</p></caption><graphic xlink:href="molecules-25-05666-g001"/></fig><fig id="molecules-25-05666-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Two-dimensional (<bold>a</bold>) and three-dimensional (<bold>b</bold>) structure of hypericin [<xref rid="B97-molecules-25-05666" ref-type="bibr">97</xref>].</p></caption><graphic xlink:href="molecules-25-05666-g002"/></fig><fig id="molecules-25-05666-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Structural formula of emodin.</p></caption><graphic xlink:href="molecules-25-05666-g003"/></fig><fig id="molecules-25-05666-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Structural formula of quinizarin.</p></caption><graphic xlink:href="molecules-25-05666-g004"/></fig><fig id="molecules-25-05666-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Structural formula of danthron.</p></caption><graphic xlink:href="molecules-25-05666-g005"/></fig><table-wrap id="molecules-25-05666-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-05666-t001_Table 1</object-id><label>Table 1</label><caption><p>Physical and chemical properties of selected photosensitizers (hypericin, emodin, quinizarin, and danthron).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Photosensitizer</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Hypericin</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Emodin</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Quinizarin </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Danthron</th></tr></thead><tbody><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Hydrophobicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">high</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">amphiphilic with mild hydrophobicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">low</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">AlogP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.040</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.568</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.324</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.324</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Absorption maximum<break/>in DMSO &#x003bb;<sub>max</sub> (nm)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">560<break/>600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">440</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">475</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">430</td></tr><tr><td rowspan="2" colspan="2" align="center" valign="middle" style="border-bottom:solid thin">Fluorescence maximum<break/>&#x003bb;<sub>exc.</sub> (nm)</td><td align="center" valign="middle" rowspan="1" colspan="1">603</td><td align="center" valign="middle" rowspan="1" colspan="1">520</td><td align="center" valign="middle" rowspan="1" colspan="1">540</td><td align="center" valign="middle" rowspan="1" colspan="1">575</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">560</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">440</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">475</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">430</td></tr><tr><td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Dissociated form (nm)</td><td align="center" valign="middle" rowspan="1" colspan="1">PS<sup>0</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">560</td><td align="center" valign="middle" rowspan="1" colspan="1">440</td><td align="center" valign="middle" rowspan="1" colspan="1">475</td><td align="center" valign="middle" rowspan="1" colspan="1">430</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PS<sup>1-</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">600 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">480</td><td align="center" valign="middle" rowspan="1" colspan="1">560</td><td align="center" valign="middle" rowspan="1" colspan="1">475</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PS<sup>2-</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">650 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">525</td><td align="center" valign="middle" rowspan="1" colspan="1">595</td><td align="center" valign="middle" rowspan="1" colspan="1">500</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">PS<sup>4-</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">630 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PS<sup>6-</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">640 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Dissociated constant</td><td align="center" valign="middle" rowspan="1" colspan="1">pKa<sub>1</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">2 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">7.2</td><td align="center" valign="middle" rowspan="1" colspan="1">11.3</td><td align="center" valign="middle" rowspan="1" colspan="1">10.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pKa<sub>2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">7.8 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">10.6</td><td align="center" valign="middle" rowspan="1" colspan="1">12.7</td><td align="center" valign="middle" rowspan="1" colspan="1">12.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pKa<sub>3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">11.5 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pKa<sub>4</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 [<xref rid="B127-molecules-25-05666" ref-type="bibr">127</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table></table-wrap></floats-group></article>